pdf, 1.15 MB - Sandwell and West Birmingham CCG
Transcription
pdf, 1.15 MB - Sandwell and West Birmingham CCG
Sandwell and West Birmingham Clinical Commissioning Group Governing Body Meeting Date: Wednesday 24th April 2013 Time: 12.30-14.45 nd Venue: Boardroom, 2 Floor Front, Kingston House, High Street, West Bromwich B70 9LD Room: Boardroom AGENDA Non-Confidential Item Subject INTRODUCTION 1. Welcome and Introductions 2. Apologies for Absence: Dr N Pall 3. Declarations of Interest Lead Time Verbal Verbal Dr N Harding Dr N Harding 12.30 12.35 Verbal Dr N Harding 12.40 To request members to disclose any interest they have, direct or indirect, in any items to be considered during the course of the meeting and to note that those members declaring an interest would not be allowed to take part in the consideration or discussion or vote on any questions relating to that item. Minutes of Previous Meeting held on 27th March Enc. 1 2013 5. Action Register Enc 2 Verbal Chairman’s Report 6. Verbal Questions from the Public 7. Enc 3 Chief Officers Report 8. 9. Governance 9.1 Corporate Objectives Enc 4 & 4a 9.2 Declarations of Interest Report Enc 5 9.3 Engagement Scheme Enc 6 10. Performance Enc 7 10.1 Finance Report Enc 8 10.2 Performance Report Enc 9 10.3 Quality and Safety Committee Report Enc 10 10.4 Strategic Commissioning and Redesign Verbal 10.5 Partnerships Committee Report Verbal 10.6 Audit Committee Report 10.7 Organisational Development Committee (No 10.8 meeting held since last governing body) 11. Minutes for Information (All minutes available on CCG Website) 11.1 Finance and Performance Committee Minutes Enc 11 Enc 12 11.2 Quality and Safety Committee Minutes Enc 13 11.3 Strategic Commissioning & Redesign Minutes No Meeting 11.4 Partnership Committee Minutes No Meeting 11.5 Audit Committee Report Minutes 11.6 Organisational Development Committee Minutes No Meeting Enc 14 11.7 Sandwell Health Alliance LCG Enc 15 11.8 Black Country LCG Enc 16 11.9 ICOF LCG 4. Dr N Harding 12.45 Dr N Harding Dr N Harding Dr N Harding A Williams 12.50 12.55 13.05 13.10 A Hodgson A Hodgson J Dicken 13.15 13.35 13.40 J Green J Green Dr Mukherjee Dr G Solomon Dr Andreou J Jasper Dr Harding 13.50 14.00 14.10 14.20 14.30 14.35 All 14.40 11.10 HealthWorks LCG 11.11 Pioneers for Health LCG 12. ANY OTHER BUSINESS Enc 17 Enc 18 13. DATE AND TIME OF NEXT MEETING Wednesday 29th May 2013 Boardroom, 2nd Floor Front, Kingston House CLOSE OF MEETING 14.45 Resolution adopted from the Public Bodies (Admission to Meetings) Act 1960: That those representatives of the press and other members of the public be excluded from the remainder of the meeting having regard to the confidential nature of the business to be transacted, publicity on which would be prejudicial to the public interest. Guidance on Declarations of Interest Definition of Interests A Governing Body/Committee member has a personal interest if the issue being discussed at a meeting affects the well being or finances of the member, the member’s family or a close associate more than most other people who live in the area affected by the issue. Personal interest are also things related to an interest the member must register such as outside bodies to which the member has been appointed by the PCT or membership of certain public bodies. A personal interest is also a prejudicial interest if it affects the finances of the member, the member’s family or a close associate and which a reasonable member of the public with knowledge of the facts would believe it likely to harm or impair the member’s ability to judge the public interest. Declaring interest If a member has an interest, they must normally declare it at the start of the meeting or as soon as they realise they have the interest. If a member has a personal and a prejudicial interest, they must not debate or vote on the matter and must leave the room. Enc No. 2 SWBCCG Board Meeting Action Register Wednesday 24th April 2013 Action 281112 By Whom Hodgson 191212 1 Feb 2013 Meeting needs to be rearranged with Sandwell 8.1 Sandwell and West Birmingham CCG Constitution Develop communication to support the Lynda publication of the Draft Constitution to seek Scott/Alison comments. 191212 Comment / Response Date Completed 7.6 Commissioning Redesign Committee Report To meet with members of the Local Andy Williams Authority to discuss the changes to the Locally Enhanced Services. 281112 Deadline / update 7. Chairman’s Report To invite Toby Lewis, Chief Executive of Nick Harding Sandwell and West Birmingham Hospitals to visit the CCG. CCG Research Presentation To further consider the gender issue and Andy Williams models and strategies that can be adopted to encourage females to take positions on Governing Bodies. December 2012 May 2013 The Constitution was ratified at the 3rdApril 2013 meeting of the Governing Body and is on the website. Has been invited to attend in May Ongoing February 2013 3rd April 2013 May 2013 Action 191212 191212 27213 27213 By Whom Chief Officers Report To set up a debriefing process to review the Nick Harding winter pressures and urgent care Risk Sharing Agreement To further explore the options for entering James Green into a Risk Sharing Agreement Organisational Development Report To develop a glossary of terms used. Central Care Records To review the extent of possible miscoding. Deadline / update March 2013 January 2013 Alison Hodgson Comment / Response This is currently happening regionally and a process will happen locally. This has not happened due to the risk regarding CCG funding Completed On going Dr N Harding To provide the detail of what information Dr N Harding will be recorded as part of the Central Care Record. 27213 27313 2 Any Other Business To explore the issue of Dudley Consultants Claire Parker providing letters to GP in Sandwell regarding their patients. Finance Report The proposed budget was accepted but due James Green to significant risks the governing body wish to be kept informed of progress. Ongoing April 2013 Date Completed Action 27313 3 By Whom Any Other Business To ensure chairs of Governing Body Alison Hodgson Committees are aware that the minutes are in the public domain and therefore should provide clear and concise. Also noted a number of items are deferred due to lack of attendance and chairs of committees to make sure a deputy attends or a report is provided. Deadline / update April 2013 Comment / Response Date Completed 24th April 2013 Enc 3 Report Topic: Accountable Officer’s FAQ Report From: Andy Williams - Accountable Officer Date: 24th April 2013 Provide an overview to the Board around the following key areas: Aim of Report • • • Finance Activity Quality RECOMMENDATIONS For Information IMPLICATIONS: Financial N/A Patient & Public Involvement N/A Healthcare Commissioning N/A Equality Impact Assessment/Diversity Impact N/A Engagement (Clinical or Non Clinical) N/A Legal N/A Vision and Values N/A Workforce N/A Other N/A Theme Finance Activity Quality Area QIPP Comment SWB CCG is currently forecast to be £3m under a target of £16.9m by the end of the financial year, although potential savings against innovation funds have not yet been incorporated into this shortfall. Control total Surplus of £6.5m by year end. Achievement of required surplus of £6.976 in line with the agreed Strategic Health Authority control total. CCG Activity Numbers @ Point of Delivery YTD Plan YTD Actual February 2013 Non Elective 63,099 67888 GP Referrals 118,349 129428 (Using HoB data as proxy for Other Referrals 80,933 85,885 West Birmingham) First OP (GP referrals) 94,824 96,377 First OP (All) 173,720 177,742 Electives 71,582 66,629 Missed Performance A&E: Year to date performance at HEFT and SWBH is below the required 95% standard. The CCG Indicators as lead commissioner has issued an improvement trajectory and performance notices to SWBH NHST. 18 Weeks Referral to Treatment: Local providers have missed the November 90% admitted target in the following Specialties : SWBH (T&O, Plastics) and WHT (T&O) CCG Diagnostic Waits: CCG wide – 62 patients waited longer than the 6 weeks equating to 0.78% of patients, below the 1% threshold. At SWBH – 59 patients waited longer than 6 weeks, equating to 0.89% of patients, again below the 1% threshold. Urgent Care Escalation Escalation levels across all urgent care sites remain high on a consistent basis across the Birmingham and Black Country health economy. SHA Ambitions Eliminate Avoidable Pressure Ulcers: CQUIN measures in place to assess and pre-determine avoidable pressure ulcers and accountability meetings have been established with the Chief Nurse where Matrons and Ward Managers are called to account for every grade 3/4 hospital acquired avoidable sore. RAG Amber Green Red Red Red Red Red Green Red Red Red Red Green Improve Quality and Safety in Primary Care: The CCG is currently in the process of adopting the West Midlands Primary Care Quality Template Create a Revolution in Patient and Customer Experience: SWBH are currently achieving a Net Promoter score of 67% against a baseline of 65%. The CQUIN for 2012/13 is to improve by 10%. Make Every Contact Count: CQUIN measure are in Place with providers to ensure that trained staff provide brief advice in particular to all those on the district nurse caseload, those who drink at harmful levels accessing acute care and new mothers seen by health visitors. Strengthening Partnerships Between the NHS and the Local Authority: Health and Well Being Board established, reviewing joint Commissioning arrangements and memorandum of understanding with public health signed. Never Events No Never Events were reported in December CQC Concerns No CQC Concerns SWBH UHB HEFT BWH BCHC BSMH WMAS Key to NHS Provider Abbreviations Sandwell and West Birmingham Hospitals DGH Dudley Group Foundation Trust University Hospitals Birmingham RWHT Royal Wolverhampton Hospital Heart of England Foundation Trust WHT Walsall Hospital Trust Birmingham Women’s Hospital ROH Royal Orthopaedic Hospital Birmingham Community Healthcare BCH Birmingham Children’s Hospital Birmingham and Solihull Mental Health Trust BCPFT Black Country Partnership Foundation Trust West Midlands Ambulance Service Amber Green Amber Green Green Green Enclosure No: 5 GOVERNING BODY Report Topic: Declarations of Interest Register 2013/14 Report From: Alison Hodgson, Head of Quality, Risk and Safety Date: 24th April 2013 Aim of Report The Governing Body members are asked to approve the Declarations of Interests Register for all Sandwell and West Birmingham Clinical Commissioning Group Members. This is a requirement for Sandwell and West Birmingham Clinical Commissioning Group members under Standing Orders set out in the Constitution. Discussion Points RECOMMENDATIONS For Information Members of Sandwell and West Birmingham Clinical Commissioning Group are asked to: 1. Approve the Sandwell and West Birmingham Clinical Commissioning Group Declarations of Interest Register. IMPLICATIONS Financial Patient & Public Involvement Equality Impact Assessment/Diversity Impact Healthcare Commissioning Engagement (Clinical or Non Clinical) Legal Vision and Values Workforce None None Not Applicable All Director Checked [Initials] Date Received by Committee Secretary 1 10/4/13 SWBCCG Governing Body Register of Interests – February 2013 NAME MEMBERS Nick Harding ORGANISATION • INTEREST • Partner and property share owner. • • • • • partner and director of subsidiary companies Trustee GP trainer, GP examiner Appointed doctor Appointed doctor • • Handsworth Wood medical centre. Partner and property share owner. Vitality Partnership Vineyard Churches UK & I. Royal college of GP Home Office – Birmingham Crematorium Health & Safety Executive for Asbestos, Ionising Radiation, and Lead medicals Maritime Coastguard Agency Faculty of Medical Leadership & Management • • Appointed doctor Member Niti Pall • • • • • • • • Smethwick Medical Centre PHD CIS PHIPL – India IDF DPF Euradia NED NHS Alliance • • • • • • • • Partner Director/Chair Director/Chair Board Member Chair Board Member Expert CIC Executive Board Member Basil Andreou • • • QOF Sandwell local medical committee sponsored by drug companies • • • Lead Minor Surgery Provider Secretary Teacher at Educational Events • • • • • SWBCCG BOARD REGISTER OF INTERESTS: UPDATED FEBRUARY 2012 NAME Priyand Hallan ORGANISATION • GP Solutions UK • Wife Nurse Practitioner • • Principal-Newtown and Aston Pride Health Centres Director ICOF LLP and GGP.Com Ltd SWBH • • Founder member of both companies Wife is Clinical Nurse Specialist Inderjit Marok • • • • Rotton Park MC Summerfield Group practice GPP.com ICOG LLP • • • • GP principal Partner Director Director Vijay Bathla • • • • • • Principal GP senior Partner Member and Executive member Chairman • PMS practice Birmingham LMC Birmingham British International Doctors Association Pioneers for Health LCG • Chairman Sirjit Bath • WRM Ltd • Director George Solomon • • Black Country Family Practice Tipton Care Organisation • • Director Co-Chair Sam Mukherjee • INTEREST • Spouse holds directorship SWBCCG BOARD REGISTER OF INTERESTS: UPDATED FEBRUARY 2012 NAME Ian Walton Ranjit Sondhi ORGANISATION • Ryland View Nursing Home • Spires Health Care • Tipton Care Organisation • Primhe • British Society of Clinical and Academic Hypnosis • Lilly pharmaceuticals • ASD Metals • Horseley Heath Surgery and Tandon Medical Centre • INTEREST • Partner • Associate • Chair • Chair • Course Organiser • Paid speaker • Medical Adviser • Partner and Owner of Share in the Property CCG Board. Not associated with any member practice. Lead lay member on patient and public engagement at Board level Trustee – PMA Trust Trustee – Nishkam Health Care Trust Chairman of Advice Birmingham – a partnership of voluntary organisations • Vice Chairman • • • Trustee Trustee Chairman • Women’s Hospital Birmingham • • • Judicial Appointments Commission Criminal Cases Review Commission Baring Foundation • • • • Wife (Anita Bhalla) is non-executive Director Commissioner Commissioner Trustee • • • SWBCCG BOARD REGISTER OF INTERESTS: UPDATED FEBRUARY 2012 NAME Felix Burden Andy Wakeman ORGANISATION INTEREST • Burdens of Disease • Director • Committee of Diabetes UK • Member/healthcare professional • Langton Medical Group, Lichfield • Spouse is GP Principal • Public Health/ Deputy DPH, BSOL Cluster. • Consultant • Employment to move to Birmingham City Council w.e.f 1st April 2013 • Member • British Medical Association, • Board member • Royal College of GPs and Faculty of Public Health • Member • Council of Faculty of Sports & Exercise Medicine Julie Jasper • • • • • Weetlands Associate Black Country Cluster Board Thorns Community College Stourbridge College Corporation Dudley CCG • • • • • Managing Director Non-Executive Director Chair Governor Member Margot Warner • • • • • Nursing and Midwifery Council Warner Healthcare Birmingham and Solihull NHS Cluster Royal College of Nurses GMB Union • • • • • Member Director and Owner Senior Nurse Member Member Richard Nugent • Principal Healthcare Estates consultancy service (HECS) Architects Sandwell college Warley Woods Community Trust • • • SWBCCG BOARD REGISTER OF INTERESTS: UPDATED FEBRUARY 2012 • • Trustee Director NAME ORGANISATION Janette Rawlinson • Just Real Solutions – independent consultancy • Cerebral Palsy Midlands • SCVO • Institute of Directors INTEREST • Owner/principal consultant • Clients of Just Real Solutions • Clients of Just Real Solutions • Member Andy Williams • My partner works as a senior manager in the Commissioning Support Unit that the CCG contracts with. • James Green • None Registered • None Registered Claire Parker • Birmingham Crisis Centre- Women’s refuge for Domestic Violence with direct links to Safeguarding • Trustee and Vice Chair Sharon Liggins • None Registered • None Registered Alison Hodgson • None Registered • None Registered SWBCCG BOARD REGISTER OF INTERESTS: UPDATED FEBRUARY 2012 24th April 2013 Enc 6 Report Topic: Report From: Sandwell and West Birmingham CCG Quality and Engagement Scheme 2013/14 Dr Pri Hallan, GP Director Mohammed Khalil, Senior Commissioning Manager Jon Dicken, Chief Officer (Operations) Date: 24 April 2013 Aim of Report To update the Governing Body on the Quality and Engagement Scheme for 2013/14 1 The Governing Body are recommended to note the contents of the report. 2 Agree delegated authority for the Remuneration Committee to RECOMMENDATIONS sign off the Quality and Engagement Scheme for 2013/14 3 Agree to the implementation of the Quality and Engagement Scheme subject to Remuneration Committee sign off IMPLICATIONS: Financial A total of £1.1 million has been set aside for this scheme. Patient & Public Involvement Details of the scheme will be shared through Patient Participation Groups. Healthcare Commissioning Improved engagement of practices will strengthen the CCG’s decision making and commissioning. Equality Impact Assessment/Diversity Impact Engagement (Clinical or Non Clinical) An initial Equality Impact Assessment has indicated that the scheme will not adversely affect care to any particular protected group. Care will be delivered where appropriate to patients within the primary and community care setting rather than the acute setting. A full Equality Impact Assessment will be undertaken at the end of the scheme to assess areas for any impact or discrimination. The scheme development has involved clinicians and managers through the Strategic Commissioning and Redesign Committee and through working groups set up to develop the scheme. Tier 3 has been developed by the Medicines Management Team. GP Directors have been engaged through the Directors meeting. Legal The proposed scsheme wil: Vision and Values • • Engage practices with CCG and Locality Commissioning Group objectives Improve primary care quality and capacity • Workforce Other Improve quality and cost effectiveness of prescribing SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP Report to the Governing Body Subject: Date: Author: Sandwell and West Birmingham CCG Quality and Engagement Scheme 2013/14 24 April 2013 Dr Pri Hallan, GP Director Mohammed Khalil, Senior Commissioning Manager Jon Dicken, Chief Officer (Operations) Introduction Sandwell and West Birmingham CCG is a large and progressive Clinical Commissioning Group with commissioning responsibility for some 530 000 patients spanning two Local Authorities, in addition the CCG has taken on lead commissioner responsibilities for a number of key developments across Birmingham, Solihull and the Black Country and indeed West Midlands wide. The views and involvement of the CCG member practices in the day to day business of the organisation are crucial to its decision making and success going forward. The CCG also has a very strong focus upon quality and service improvement. The CCG has therefore proposed the development and implementation of a quality and engagement scheme for 2013/14. The sum of £1.50 per registered patient has been set aside for 2013/14 to incentivise practices to engage with and support the implementation of key CCG objectives. In addition a further £300, 000 is available for incentives relating to prescribing. The proposed scheme has been developed to reflect the aims and objectives of the CCG and to engage member practices with CCG activity; focus upon primary care development and quality; and improve prescribing. Progress Update The development of the proposed scheme has been clinically led by Dr Pri Hallan and reported through the Commissioning Business Planning Group (a sub group of the Strategic Commissioning and Redesign Committee), the Strategic Commissioning and Redesign Committee and the Directors Group. The proposed scheme was presented to the CCG Remuneration Committee on 21 March 2013 and members asked for further work to be undertaken to clarify a number of points of detail to ensure that the appropriate governance processes have been followed prior to implementation. The required work has been completed and the proposed scheme is due to return to the Remuneration Committee before the end of April. The next step subject to agreement by Remuneration Committee is the implementation of the scheme. Conclusion The involvement of CCG member practices is crucial to the success of the organisation in terms of the achievement of its aims and objectives. The timely implementation of the proposed scheme is clearly very important in this regard and it is therefore proposed that delegated authority should be given to the Remuneration Committee to sign off the scheme once members are satisfied with the rationale and governance. This will enable immediate implementation without further delay once approval has been given. Recommendations The Governing Body are recommended to 1 Note the contents of the report. 2 Agree delegated authority for the Remuneration Committee to sign off the Quality and Engagement Scheme for 2013/14. 3 Agree to the implementation of the Quality and Engagement Scheme subject to Remuneration Committee sign off. Contact Dr Pri Hallan, GP Director Mohammed Khalil, Senior Commissioning Manager Jon Dicken, Chief Officer (Operations) Enc 7 Sandwell and West Birmingham CCG Finance and Performance Committee Finance and Activity Report Report Topic: Finance and Activity Report as at 31st March 2013 Report From: James Green – Chief Finance Officer Date: 22nd April 2013 Purpose of the Report To provide information to the committee on the financial performance of the CCG for the 2012/13 financial year. • • • • Key Issues Summary End of year surplus position of £7.5m Prescribing budgets contributing £5.4m to end of year surplus QIPP reported as achieving £800,000 less than £16.97m Target NHS Trust activity over spend by nearly £3.5m Members of the Committee are asked to: Recommendations 1. 2. Discuss the content of the report Note the contents of the report and associated risks Enc 7 1. Executive Summary Performance for Sandwell and West Birmingham CCG a surplus position of £7.5m which is line with the forecast agreed with the Strategic Health Authority. Key Finance Performance Delegated Statutory Duties Financial Balance Total QIPP Target Plan (£m) Surplus £6.98 £16.97 Year to Date (£m) Surplus £7.09 £16.17 G A Acute activity posted a deficit position of £3.449m based on validated activity and final agreements with trusts. Information has been validated for April to January for most trusts and it remains a risk that further activity is a cost pressure to SWB CCG in the 2013/14 financial year. Prescribing performance remains strong with a final surplus of £5.4m at the year end. This is in line with previous forecasts. Community spend was £1.166m lower than planned due a successful scheme to control the costs of complex packages of care in BSOL. Table 1: Sandwell & West Birmingham CCG Summary Financial Position – Month 12 Annual Budget £000's Spend £000's Surplus/ (Deficit) £000's Acute Prescribing Community Mental Health and Learning Disabilities Contingency & Other (inc Running Costs) Planned Surplus 352,683 84,885 118,015 75,272 23,342 6,976 356,131 79,509 116,849 75,340 25,935 (112) (3,449) 5,376 1,166 (68) (2,593) 7,088 Total SWB CCG 661,173 653,652 7,520 Enc 7 2. Acute Contract Performance NHS Trust performance information has been validated for April to January of the 2012/13 financial year, with indicative data for February and financial estimates made for March. Figure 1 below sets out the forecast outturn position for the major acute contracts for the CCG. £3,500 £3,000 £2,500 £2,000 £1,500 £1,000 £500 -£1,000 WMH SWBH RWH UHB ROH HEFT DGH BWH -£500 BCH £- Thousands M12 M11 M10 M9 M8 M7 M6 M5 M4 M3 M2 Acute activity posted a deficit position of nearly £3.5m based on known activity; including some final agreements with trusts. Information has been validated for April to January for most trusts. Final settlements have been reached with Sandwell & West Birmingham NHST as well as a number of trusts where the CCG is an associate commissioner. These agreements are full and final and no further charges are expected from those providers. There is however a risk that expenditure is charged once activity is finalised from Dudley Group of Hospitals amongst others. Any activity charged over and above accrued amounts will be charged to SWB CCG and will represent a cost pressure in 2013/14 budgets. Enc 7 3. Prescribing Prescribing performance data has been received from the PPA for February 2013, which shows a surplus position of £5.4m. Precribing £000’s Previous month’s performance was in line with the PPA forecast and the end of year position remains on track. 86,000 However, any costs over and above this forecast will be incurred by the CCG. 82,000 84,000 80,000 78,000 76,000 Plan Spend 4. Quality Innovation Productivity and Prevention (QIPP) The CCG has a QIPP target of £16.97m for the 2012/13 financial year. Final performance is still being finalised but indications are that the target will be missed by £800k. The majority schemes have been built into contractual arrangements with SWBH. QIPP - Forecast to Target Forecast Target £000’s 15,500 16,000 16,500 17,000 Sandwell PCTs latest report shows a forecast over performance of £107k by the end of the year. HoB PCT is forecasting a short fall of £924k which will be offset by non-recurrent measures such as the release of PCT held contingencies. Enc 7 The chart below sets out performance against the main QIPP categories. QIPP £000’s 10,000 8,000 6,000 4,000 2,000 Other PCT Running Costs Primary Care Prescribing Forecast Continuing Healthcare Target Community Acute 0 5. Transition Year 2012/13 During 2012/13 the statutory duty for financial balance remains with Sandwell PCT and Heart of Birmingham PCT (HoB). As such the financial position of the separate Sandwell and HoB practices will be reported to the respective PCT Cluster boards. As shown in table 3 below SWB CCG summary financial position is split showing that Sandwell practices are forecasting a £9.1m surplus and HoB practices forecasting a deficit position of £1.6m. Table: SWB CCG Financial Summary by PCT Cluster Annual Budget £000's Spend £000's Surplus/ (Deficit) £000's Black Country PCT Cluster Birmingham & Solihull PCT Cluster 410,918 250,254 401,780 251,872 9,138 (1,618) Total SWB CCG 661,173 653,652 7,520 Enc 7 6. Statement of Financial Position at 31 March 2013 – Sandwell PCT 31 March 2013 31 March 2012 £000 £000 Non-current assets: Property, plant and equipment Intangible assets investment property Other financial assets Trade and other receivables Total non-current assets £000s 0 31,851 0 0 31,851 £000s 0 31,527 102 0 31,629 Current assets: Inventories Trade and other receivables Other financial assets Other current assets Cash and cash equivalents Total current assets 32,596 0 0 9,203 0 41,799 32,104 0 0 8,163 0 40,267 0 0 41,799 73,650 40,267 71,896 42,981 0 (41,561) 0 (3,287) (1,867) 40,982 0 (42,680) 0 (4,373) (6,071) Non-current assets plus/less net current assets/liabilities 71,783 65,825 Non-current liabilities Trade and other payables Other Liabilities Provisions Borrowings Other financial liabilities Total non-current liabilities (2,355) 0 0 0 (2,018) (4,373) (6,549) 0 0 0 (1,008) (7,557) Total Assets Employed: 67,410 58,267 0 0 (23,362) (23,362) 0 0 (27,393) (27,393) Non-current assets held for sale Total current assets Total assets Current liabilities Trade and other payables Other liabilities Provisions Borrowings Other financial liabilities Total current liabilities Financed by taxpayers' equity: General fund Revaluation reserve Other reserves Total taxpayers' equity: Enc 7 7. Capital Resource Limit Sandwell PCT has a statutory duty to keep within the Capital Resource Limit (CRL) set by the Strategic Health Authority. Sandwell PCT reported a surplus of £309k in the 2012/13 final accounts. Capital Resource Limit Charge to Capital Resource Limit (Deficit)/Surplus Against CRL 2012-13 £000 2011-12 £000 5,112 4,803 309 10,017 10,008 9 8. Conclusion Sandwell and West Birmingham CCG have a financial surplus of £7.5m the end of the financial year 2012/13 on an overall budget of £655m. This surplus was is required to deliver the CCG’s delegated element of the Sandwell PCT target surplus. 9. Recommendations Members of the F&P Committee are asked to: 1. Discuss the contents of the report; 2. Approve the contents of the report; Contact Officers James Green – Chief Finance Officer – JMGreen@nhs.net Paul Sheldon – Deputy Chief Finance Officer – paul.sheldon@sandwellandwestbhamccg.nhs.uk Enc 8 Sandwell and West Birmingham CCG Board Key Indicators Performance Report Report Topic: Key Indicators Performance Report – as at January 2013 Report From: James Green – Chief Finance Officer Date: 24th April 2013 Aim of Report To provide information to the Board on the performance of the CCG against key indicators for the 2012/13 financial year. Discussion Points • • • • RECOMMENDATIONS A&E and Urgent Care 18 Weeks Referral to Treatment Diagnostic Waits Mixed Sex Accommodation Members of the Committee are asked to: 1. 2. Discuss the content of the report Approve the contents of the report Enc 8 1. Introduction This report presents the most to up to date position for Sandwell and West Birmingham CCG (SWB CCG) against key performance indicators. The overall performance of the CCG is good against both the key requirements of the Operating Framework and against the quality requirements contained within the acute contract. There are a few areas of concern which are indicated below with more detail about why the performance is below the required standard and options for rectification. 2. A&E and Urgent Care Figure one below shows the outturn position of the all Birmingham and the Black Country providers (including walk in centres) against the Operating Framework indicator for 4 hour waits against the standard of 95% seen within that timeframe. Trusts are measured on their performance on a monthly basis as part of the contract review process although no financial penalty is attributable until the end of the financial year when the outturn position is agreed (2% of the actual outturn value for the service line). A&E All Types Birmingham Birmingham Children's Hospital NHS Foundation Trust Heart of England NHS Foundation Trust South Birmingham GP Walk In Centre University Hospital Birmingham NHS Foundation Trust Summerfield Urgent Care Centre Birmingham Walk In Centre Assura Vertis Urgent Care Centres (Birmingham) Greet General Practice & Urgent Care Centre Birmingham Community Healthcare NHS Trust Solihull Walk In Centre Black Country Sandwell & West Birmingham Hospitals NHS Trust The Dudley Group Of Hospitals NHS Foundation Trust The Royal Wolverhampton Hospitals NHS Trust Walsall Healthcare NHS Trust Dudley Borough Walk in Centre Badger Walsall OOH Walsall Walk In Centre Q1 Performance (Outturn) Q2 Performance (Outturn) Q3 Performance (Outturn) Q4 Performance (Outturn) Year to Date 97.51% 94.39% 100.00% 96.34% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.86% 93.16% 100.00% 95.55% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 96.23% 91.47% 100.00% 93.12% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.92% 85.37% 100.00% 93.77% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.34% 91.20% 100.00% 94.69% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 95.03% 97.40% 97.37% 96.15% 100.00% 100.00% 100.00% 93.54% 95.85% 96.46% 95.52% 100.00% 100.00% 100.00% 91.18% 95.06% 95.20% 94.62% 100.00% 100.00% 100.00% 89.79% 92.98% 94.01% 94.00% 100.00% 100.00% 100.00% 92.43% 95.36% 95.75% 95.02% 100.00% 100.00% 100.00% Figure 1 - A&E Performance at 31/03/2013 The table confirms that SWBH and HEFT failed to achieve the minimum standard required at the cumulative year end stage. University Hospitals Birmingham also failed to get over the line after two poor quarters of performance, reaffirming the problems that have been experienced in urgent care across the whole system. In the Black Country region the remaining three acute providers missed the target in Q4 but all had created sufficient headroom in the previous months to cover this. Enc 8 3. 18 Weeks Referral to Treatment Using January 2013 as the most up to date comparable data Figure 3 below shows the all specialties view of the 90% standard for admitted patients for the local acute providers and the CCG as commissioner (using the two constituent PCTs as a proxy). This shows that as previously reported T&O is an issue across the Birmingham and Black Country geography. Specialty Cardiology Cardiothoracic Surgery Dermatology ENT Gastroenterology General Medicine General Surgery Geriatric Medicine Gynaecology Neurology Neurosurgery Ophthalmology Oral Surgery Other Plastic Surgery Rheumatology Thoracic Medicine Trauma & Orthopaedics Urology Total Sandw ell PCT HoB PCT SWBH DGOH HEFT UHB Walsall 93.10% 86.00% 91.72% 94.29% 94.29% 93.50% 100.00% 100.00% 100.00% NA NA NA 100.00% NA 96.23% 92.31% 95.11% 100.00% 97.62% 91.03% NA 96.20% 95.65% 97.98% 97.44% 92.05% 95.35% 90.91% 100.00% 100.00% 100.00% 98.11% 100.00% 100.00% NA 95.65% 100.00% 96.34% 100.00% 100.00% 95.00% 100.00% 92.29% 96.30% 95.34% 95.09% 91.56% 90.37% 92.23% 0.00% 0.00% 100.00% NA NA 100.00% 100.00% 95.68% 88.00% 95.22% 96.15% 93.72% NA 93.17% 100.00% 100.00% 100.00% NA NA 100.00% NA 77.78% 72.73% NA NA NA 92.41% NA 93.78% 91.57% 92.13% 99.29% 91.30% 91.06% 91.03% 96.39% 92.77% 95.22% 94.00% 100.00% 95.45% 97.56% 96.95% 96.21% 97.06% 96.95% 95.72% 94.49% 100.00% 85.06% 90.91% 86.67% 95.24% NA 92.86% NA 100.00% 100.00% 100.00% 100.00% NA NA 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% NA 85.61% 84.67% 79.45% 97.52% 87.79% 96.67% 84.36% 97.21% 94.03% 96.68% 89.83% 92.34% 91.46% 96.81% 94.05% 92.73% 93.97% 96.75% 92.43% 93.45% 91.67% Figure 2 - Admitted 18 Weeks Performance (Jan 13) 4. Diagnostic Waiting Times The issue around diagnostic waits at SWBH has been resolved in February. The trust still has problems with those patients waiting for diagnostic test in the ‘oscopy’ category but the overall picture has improved so that 99% of patients waiting for the 15 diagnostic tests monitored have their test completed within 6 weeks. The table overleaf (figure 3) shows the performance of SWBH against this measure for the 11 months to February 2013. Enc 8 Diagnostics - Of all the waits for named test, what % are over 6 weeks APRIL MAY JUNE JULY AUGUST SEPTEMBER OCTOBER NOVEMBER DECEMBER JANUARY FEBRUARY AUDIOLOGY_ASSESSMENTS 1.4% 0.2% 1.1% 0.0% 0.2% 0.5% 3.4% 0.0% 0.2% 0.4% 1.2% BARIUM_ENEMA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% COLONOSCOPY 7.1% 4.4% 3.6% 0.3% 7.6% 9.0% 11.7% 15.6% 14.1% 11.3% 6.0% CT 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% CYSTOSCOPY 5.6% 2.0% 4.1% 3.0% 3.8% 12.1% 5.4% 5.5% 7.9% 4.5% 4.6% DEXA_SCAN 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% ECHOCARDIOGRAPHY 1.3% 0.6% 0.2% 0.2% 0.0% 0.8% 0.3% 0.3% 0.5% 0.5% 4.2% ELECTROPHYSIOLOGY 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 7.6% FLEXI_SIGMOIDOSCOPY 15.3% 6.8% 0.0% 0.0% 8.3% 5.8% 16.5% 21.3% 25.2% 22.0% GASTROSCOPY 4.6% 2.4% 4.2% 2.8% 8.8% 5.2% 2.8% 6.7% 7.5% 10.3% 3.0% MRI 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.1% NON_OBSTETRIC_ULTRASOUND 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% PERIPHERAL_NEUROPHYS 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% SLEEP_STUDIES 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% URODYNAMICS 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% TOTAL 1.3% 0.6% 0.6% 0.3% 1.0% 1.5% 2.0% 1.7% 1.9% 2.0% 0.9% Figure 3 - SWBH 6 Week Diagnostic Waits 5. Mixed Sex Accommodation Breaches There were two breaches of mixed sex accommodation for Sandwell patients at Royal Wolverhampton Hospital. The CCG has contacted the lead commissioner to ascertain the reasons for the breaches, where they occurred and what measures have been put in place to ensure there are no more. The CCG will also demand that the fine be levied as per the national requirements in the contract clauses. 6. Recommendations Members of the F&P Committee are asked to: 1. Discuss the contents of the report; 2. Approve the contents of the report; Contacts James Green, Chief Finance Officer, james.green@sandwell-pct.nhs.uk Martin Stevens, Head of Business and Contract Performance, martin.stevens@nhs.net 24th April 2013 Enc 9 Report Topic: Quality and Safety Report Report From: Sam Mukherjee Date: 24th April 2013 Aim of Report RECOMMENDATIONS To update the Governing Body on the work of the Quality and Safety Subcommittee and ratify any policies agreed by the committee. • Individual Funding Requests • Ethical Framework for Priority Setting and Resource Allocation • Patients Leaving Non-Commercially Funded Trials • Patients Leaving Industry Sponsored Trials • Patients Leaving a CCG Funded Trial • Implementation and funding of guidance produced by the National Institute for Health and Care Excellence • Patients Changing Responsible Commissioner • In-Year Service Developments and the Clinical Commissioning Group’s approach to treatments not yet assessed and prioritised • Experimental and Unproven Treatments • On-going access to treatment following a ‘trial of treatment’ which has not been sanctioned by the Clinical Commissioning Group for a treatment which is not routinely funded or has not been formally assessed and prioritised • SWBCCG Pol09 SALARY VARIATION The Governing Body is asked to NOTE the contents of this report and ratify decisions undertaken by the Q&S. IMPLICATIONS: Financial None Patient & Public Involvement PPI involvement in Quality and Safety committee, patient experience is an important part of monitoring and commissioning the best quality services. Healthcare Commissioning None Equality Impact Assessment/Diversity Impact None Engagement (Clinical or Non Clinical) None Legal None Vision and Values Healthcare without Boundaries- to ensure the CCG population has equity of service and an expectation that the service they receive is safe and of the highest quality. Workforce None Other SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP Report to the Governing Body Subject: Quality and Safety Subcommittee Date: 24th April 2013 Author: Claire Parker Remit of Subcommittee The purpose of the Committee is to; • • • • • provide the Governing Body with assurance that it is improving Quality and Effectiveness for patients by: Monitoring and reacting to Patient Experiences Ensuring services commissioned are safe and effective Ensuring Quality is embedded into everything the CCG delivers Update the Governing Body on any Safeguarding Issues Progress last Month The last meeting of the group was 9th April 2013 There were no Never Events reported for March 2013. For March 2013 there were: • 14 incidents opened on STEIS of which: o 10 were reported by SWBH o 3 were reported by the Black Country Partnership o 1 by CCG (transferred to B&SMHT) • 23 incidents were closed on STEIS during March 2013 o 2 closed by BCPFT o 19 closed by SWBHT o 1 closed by CCG (transferred to B&SMHT) • As at 16.4.13 there are 32 incidents open on STEIS for longer than 45 days : o 7 open for SWBHT o 23 open for BCPFT o 2 for the CCG Safeguarding Children Sandwell has had an OFSTED inspection under the interim framework- the report was published on 9th April. Sandwell has been deemed inadequate in all areas inspected. The final report is a separate agenda item for the Governing Body. The Designated Nurse will present a paper under the confidential items of the Governing Body. Datix Incident Reporting System: Up and ready to use as of 1st April 2013. Sandwell GP’s have been notified by link email but not all GP’s aware. System available for West Birmingham GP’s and quality team will be supporting the practices to implement the system. Quality report (as presented to April Q&S committee attached as appendix A) Outbreaks: Norovirus and diarrhoea and vomiting continue to remain an issue at SWBHT which has lead to a continuation in a number of ward closures and continues to impact on the urgent care system. A number of other outbreaks have been reported from the trust including Salmonella infantis and iGAS (invasive Group A Streptococcus) - the trust is investigating infection control practices and this is being monitored closely through the clinical quality review process. Mortality: National Bowel Cancer Audit- SWBHT is showing as a mortality outlier nationally. The clinical director, Neil Cruickshank has been invited to the clinical quality review meeting in April to discuss the findings of the audit and to advise on actions taken. Francis Report: A draft version of the main commissioning recommendations from the Francis report was presented to the Q&S committee with the responses of the CCG. The committee were asked to review the responses and make any comments. The responses will then be formatted into an action plan against which detailed actions, staff and dates will be aligned to show progress against the plan. The Q&S committee will manage and update the plan. The initial action plan will be presented to the Governing Body. BCPFT: There are no issues to report against BCPFT as the April children’s services meeting was cancelled by Dudley CCG. SWB CCG do not commission children’s services from BCPFT. A meeting with Wolverhampton CCG was arranged to have one joint clinical quality review process for BCPFT, this was agreed and will commence in June 2013. Risk Register The risk register will remain as a regular item on the Q&S committee. Risks around safeguarding and infection prevention were identified. Emergency Department There are no significant updates relating to quality and safety in the emergency department; however performance continues to be an issue. The Emergency department assurance group for April was cancelled due to system pressures and therefore a chance to discuss the action plan did not take place. Medicines Optimisation and Individual Funding Requests A number of IFR policies were presented for ratification at the April meeting for Governing Body ratification: • Individual Funding Requests • Ethical Framework for Priority Setting and Resource Allocation • Patients Leaving Non-Commercially Funded Trials • • • • • • • Patients Leaving Industry Sponsored Trials Patients Leaving a CCG Funded Trial Implementation and funding of guidance produced by the National Institute for Health and Care Excellence Patients Changing Responsible Commissioner In-Year Service Developments and the Clinical Commissioning Group’s approach to treatments not yet assessed and prioritised Experimental and Unproven Treatments On-going access to treatment following a ‘trial of treatment’ which has not been sanctioned by the Clinical Commissioning Group for a treatment which is not routinely funded or has not been formally assessed and prioritised Policies for ratification by the Governing Body: • SWBCCG Pol09 SALARY VARIATION Work Plan for Next Month • Monitor Infection Prevention Strategies through clinical quality review process • Recruitment of staff to Quality Teams • Safeguarding team review to support child protection in Birmingham and Sandwell Issues for escalation to Governing Body Note no Never Events OFSTED for Sandwell Safeguarding board is inadequate Note the Serious Incidents reported and the closure of incidents. Infection prevention issues at SWBHT QUALITY REPORT April 2013 1 OVERVIEW 1.1 Introduction 1.2 Key Points 1.3 Provider summary 2 PATIENT SAFETY 2.1 Serious Incidents 2.2 HCAI 2.3 Medicines management 2.4 Safeguarding 3 CLINICAL EFFECTIVENESS 3.1 NICE Quality standards 3.2 Appreciative Enquiry 3.3 Mortality 4 PATIENT EXPERIENCE 4.1 Net Promoter 4.2 Complaints/PALS 4.3 a) Complaints data b) PALS data c) PHSO cases Net promoter Page No. 1.1 Introduction This report is intended to inform the committee on areas of clinical quality on which the CCG are currently focussed. This provides the opportunity to scrutinise, challenge and to inform further lines of enquiry or actions which can then be monitored through a recorded process. 1.2 Key Points SWBH update Many of the Trust’s medical wards are giving rise for concern especially with regard to staffing arrangements – we are taking additional steps to try to resolve this issue and have this month seen signs of improvement with a reduction in sickness absence on many wards, improved vacancy rate and positive signs with key quality metrics. L4 is alerting in several areas and is therefore receiving targeted assistance. BCPFT update – intended future joint CQRM with Wolverhampton CCG 1.3 Provider summary SWBH Quality Report • Safety Thermometer results in February improved to 96%. This is the first month that the Trust has achieved the 95% harm free target. The largest reduction in harm events is within pressure damage. No patients experienced more than one harm event. • Falls in January decreased from the November and December position. The biggest reduction in falls events occurred at Sandwell. • Infection rates – there have been further problems with Norovirus in February with a different and more virulent strain affecting the community and hospital. C diff rates increased, especially at Sandwell although both C diff and MRSA remain within trajectory for the year. • Pressure Damage – There were 14 avoidable hospital acquired pressure sores reported in December. Of these there were no grade 4 sores and a total of 3 grade 3 sores. This represents a continuing improving picture over the year. • Nutritional assessments on admission are back to an acceptable level but repeat assessments still need improvement. • Bank/agency (nursing) increased in February to just under 7000 shifts. This is related to additional staffing requirements for ‘specialling patients’ in the EDs and to cope with lack of flexibility around outbreak wards. • Staffing ratios – the vacancy position and sickness absence position improved in February as a result of recruitment, closing of some beds and robust absence management. There has also been some improvement in quality measures with less wards showing concerning trends. Actual staffing levels are being maintained but often with high bank/agency use and poor skill mix. Outbreaks Targets 2012/13: C difficile – 57 cases (post 48 hours, using SHA testing methodology) (National Priority MRSA – 2 cases (post 48 hours) Local contract) MRSA Screening – 85% eligible patients Blood culture contaminants – 3% or less E Coli and MSSA – Continue to record and TTR device related infections National cleanliness standards – 95% MRSA There were no post-48 hour MRSA bacteraemia for Febuary. The total number of MRSA bacteraemias against the Trust target to date is 1. Mortality As part of the Trust’s annual contract agreement with the commissioners the Trust has agreed a CQUIN scheme with an end year target to review 80% of hospital deaths within 42 working days. During the most recent month for which complete data is available (December) the Trust reviewed 66% of deaths compared with a target trajectory for the month of 74.0%. The Trust has failed to meet the trajectory for December. Operational pressures within the trust have had effects on many parts of the organisation and carrying out mortality reviews has not escaped. In addition, the Trust has developed and implemented a revised Mortality Review System which will spread the burden of carrying out reviews more equitably across the medical specialities. This is planned to result in more deaths being reviewed as required. CQC Mortality Alerts received in 2012/13 Perinatal Mortality The Trust received notification from the CQC on 18th December 2012 of being an outlier for perinatal mortality. An investigation report has been submitted to the Commission on 7th January. A response from the CQC was received on 18th February indicating that they did not wish to undertake any further enquiries at this time. Elective Caesarean Section rates The Trust received notification from the Care Quality Commission on the 18th February 2013 of being an outlier for elective caesarean section rates. The Commission indicated that following the consideration of maternity indicators, their analysis had indicated significantly high rates of elective caesarean section at the Trust and it required further information from the in order to consider the matter further. A review of relevant cases in underway and the findings will be reported to the Commission. Complaints Some complaints continue to accrue “active” days as they have not yet been concluded and closed. This is for varying reasons and include: • • • • 6 cases where the complainant has requested a meeting 1 case where the complainant is considering their next steps 1 case where the complainant wishes to wait for the outcome of an inquest prior to receiving a response Pressure ulcers Grade 4 None Reported BCPFT The March meeting mainly concentrated on Learning Disability Services. Serious Incidents There were 6 new STEIS’ reported since the last report. There are currently 16 ongoing Serious Untoward Incidents (excluding the new STEIS’) 11 for Adult Mental Health 3 for Children, Young Persons and Families 2 for Learning Disabilities Serious Untoward Incidents Ongoing within Timeframe 6 x Adult Mental Health which 1 includes a Police Investigation 1 x Children, Young Persons and Families which is subject to a Serious Case Review Serious Untoward Incidents in Internal Process - Ongoing Outside NPSA Timeframe Learning Disability 1 x Returned to February Care Governance with amendments as requested in January however still not approved, Divisional Manager meeting with author. 1 x RCA sent to Serious Incident Scrutiny Group for approval. Adult Mental Health 1 x RCA completed awaiting Divisional Managers approval. 1 x RCA completed awaiting Care Governance approval. 1 x RCA sent to Serious Incident Scrutiny Group for approval. Alerts • There were 8 new Medical Device Alerts received during January 2013 • 4 Medical Device Alerts was reviewed and closed with no action required • 1 Medical Device Alerts was cascaded with sufficient feedback received to close alert • There was 1 overdue alert which has now been closed External Visits and Reviews A number of visits and reviews have taken place and the reports were shared at the CQRM CQC – Health Lane The CQC has undertaken a review at Health lane Hospital. This review is part of a targeted inspection programme to services that care for people with learning disabilities to assess how well they experience effective, safe and appropriate care treatment and support that meets their needs and protects their rights; and whether they are protected from abuse. CQC findings Outcome 4: People should get safe and appropriate care that meets their needs and supports their rights Patients’ needs are assessed and staff have most of the information they need to know how to meet individual needs. However, they need more information to be able to meet individual health needs. Patients do not always have information available to help them understand what their plan is about or how they are involved. For some patients activities are limited, which impacts on their well being and choice. Overall, we found that improvements are needed for this essential standard. Outcome 7: People should be protected from abuse and staff should respect their human rights Systems are in place to ensure patients are protected from abuse, or the risk of abuse. However, patients do not have the information they need to know how to report abuse and to whom, so they may not be able to do this. Patients’ human rights are respected but their privacy and dignity is not always considered. Overall, we found that Sitwell Ward was meeting this essential standard but, to maintain this, we have suggested that some improvements are made. Assurance It was confirmed that the CQC have deemed they are complaint across the division in all areas except for a minor concern relating to staff training regarding values and activity which will be followed up. Quality Review Audit Visit Gerry Simon Clinic This visit to Gerry Simon Clinic was undertaken on 12th June 2012 by Helen Pettengell. The purpose of the visit was to undertake a quality audit to provide an independent view of the services provided focusing on Outcomes 1, 2, 4, 5, 7, 8, 10, 13, 14 and 21 in order to make a judgement regarding compliance with the outcomes of the Essential Standards of Quality and Safety. The report from the quality audit would enable an action plan to be developed to address any areas of concern. The visit was not unannounced as the patients had been made aware of the visit. At the time of the visit to the ward there were 14 patients receiving care, treatment and support. Seven (50%) of patients and a number of staff were spoken with during the visit. All staff were found to be open and welcoming. During the visit, systems and records relating to the care and welfare of the patients were examined, including the care plans and associated records. Key concerns identified through the visit are as follows: There were no areas which were viewed as critical and require immediate action on this unit. Daisy Bank This visit to Daisy Bank was undertaken on 14th August 2012 by Helen Pettengall. The purpose of the visit was to undertake a quality audit to provide independent view of the services provided focusing on a number of the outcomes of the Essential Standards of Quality and Safety. Key concerns identified through the visit are as follows: General concerns for consideration: Care plans must be developed for all areas of identified need and must provide staff with adequate information to meet the person’s needs in a person centred way that upholds the service users wishes, preferences and choice. Newton House This visit to Newton House at Hallam Street was undertaken on 30th August 2012 by Helen Pettengell. The purpose of the visit was to undertake a quality audit to provide an independent view of the services provided focusing on a number of the Outcomes in order to make a judgement regarding compliance with the outcomes of the Essential Standards of Quality and Safety. Key concerns identified through the visit are as follows: As identified on the other Trust visits, to ensure the safety of patients from any ligature risks, the works plan must be agreed and timescales for completion of the work must be set. It is important that the works plan is monitored to ensure that there is no slippage and that the works plan is completed in a timely manner. Robust risk assessments must be made available on the unit to identify and manage the risks while awaiting the completion of the works plan. Staff must be aware of these risk assessments. • To ensure patients are not put at risk, allergies must be clearly identified and recorded where relevant. • The recording of capacity and consent must be consistent with other documentation within the file(s). • Consideration should be given to the current filing system and introducing Walsall Learning Disability Services This visit to the Walsall Learning Disability Service was undertaken on the 15th November 2012 by Helen Pettengell. The purpose of the visit was to undertake a quality audit to provide an independent view of the services provided in order to make a judgement regarding compliance with the outcomes of the Essential Standards of Quality and Safety. This was a positive visit with one area of identified minor non-compliance and a few recommendations for practice development/improvement to ensure continued compliance with the essential standards of quality and safety. Complaints and Compliments 48 complaints were received between October to December. This shows a 41% increase in comparison to the same period last year, when 34 complaints were received. The overall total of complaints received since April is 127 and there is a 10% increase in comparison to the equivalent period for last year (April to December 2011) when 115 complaints were received. We have seen a 60% increase in compliments, with 61 received (October to December 2012) with compared with the same period last year, when 38 were received (October to December 2011). The overall total of compliments for April to December 2012 is 183 which shows a 63% increase when compared with the same period last year, when 112 were received (April to December 2011). Workforce Trust Wide • Sickness absence for the month of November stood at 5.03%. This has been an increase since last reported on in November, however is a reduction on the previous month. • The turnover figure for the Trust continues to be well within the acceptable target range of 12.9%. • With effect from this month mandatory training is reported in two separate figures: o Percentage of staff attending the new Annual Mandatory Training Day. o Percentage of staff compliant with Specialist Mandatory Training. • The percentages of staff who have attended the new mandatory training day is 18.3%, this is since its launch at the end of October 2012. The Trust target being 95% by the end of October 2013. Feedback received by staff attending this new training day has been very positive. • The percentage of staff compliant with Specialist Mandatory Training is 54.8%, with the Trust target being 95%. This figure is a combined compliance figure of a range of mandatory training topics. It is proposed to implement the same automatic booking approach to this training as applied to the mandatory day. • Appraisal rate for the Trust as a whole continues to increase and now stands at 80.7%. This is a significant achievement for the Trust and is thanks to the hard work of all involved. • Agency, which includes both medical locums and non-medical agency costs has further reduced. 35.6% of the spend is on medical locums totalling £61,559 for the month of December. Corporate Directorates and Operational Divisions • • • • Sickness absence within Learning Disabilities continues to be above the Trust target figure of 4.5% and currently stands at 7.78%. Work is currently on-going within the Division to address this. Children’ Division currently has the highest attendance at the new annual mandatory training day with 35.57% of their staff attending since the launch. The percentage of staff compliant in specialist mandatory training in all divisions is below the target of 95%. Children’s currently stands at below 20%. The appraisal compliance target of 80% was achieved in December by Mental Health, Learning Disabilities and Corporate Services. Children’s compliance percentage for December is 68%. Mental Health have the highest usage of bank and agency (42.4% of agency spend is on medical locums totalling £61,559). Mental Health still has a substantial number of vacancies within the Division. 2.0 Patient safety 2.1 Serious Incidents Incidents Reporting of incidents continues to rise year on year which evidences an improving safety culture. This has been helped by the introduction of the electronic reporting system. Management of incidents within an agreed timeframe is important to understand trends and themes and allow for actions to be taken at the appropriate time. Incidents remain in a “holding” file until they are managed and closed. This may cause delays in addressing issues if not corrected. A targeted plan is in place to assist managers with managing their unmanaged incidents. Type of Incident 1600 1400 1200 Non clinical Number 1000 Patient Safety 800 Un assigned 600 TOTAL 400 200 0 Apr12 May12 Jun- Jul-12 Aug12 12 Sep12 Oct12 Nov12 Dec12 Jan13 Feb13 Month 2.2 HCAI C.Difficile 60 50 40 30 20 10 0 Apr-12 May-12 Jun-12 Jul-12 Sandwell Aug-12 City Sep-12 Oct-12 Threshold (cumulative) Nov-12 Dec-12 Jan-13 Feb-13 M Trust Total (cumulative) Blood Contaminant Percentage Possibly Contaminated 5.0% 4.0% 3.0% 2.0% Consultant Data City 1.0% Consultant Data Sand 0.0% 05/2012 06/2012 07/2012 08/2012 09/2012 10/2012 11/2012 12/2012 01/2013 02/201 Outbreak and Other Infection Control Activity • There were more outbreaks of diarrhoea and/or vomiting across both sites in February, mostly due to confirmed norovirus. This is thought to be due to a more virulent strain of the virus, and is causing an unprecedented number of incidents both within the community and in many • • 2.3 trusts in the region. The number of confirmed cases of Influenza A continues to rise, with many patients requiring Critical Care. The majority of cases are due to H3N2, not H1N1 (swine flu), A patient was admitted with a respiratory illness which was later confirmed to be due to novel coronavirus. He had travelled from Pakistan to the UK via Saudi Arabia. Another two family members who had not been abroad were subsequently found to be positive for novel coronavirus, confirming the ability of the virus to be transmitted from person to person. It is imperative that staff follow HPA guidelines on patients returning from abroad with signs of a respiratory illness to ensure that they are not at risk of having contracted novel coronavirus. Medicines Management Warfarin CQUIN. An audit of patients admitted taking warfarin with an INR above 5 whose dosage had been adjusted or reviewed prior to the next dose, was carried out over a 1 week period in December. Compliance of 100% was achieved. Drug Storage Audits Ward drug storage audits were carried out in January and the early results are summarised below. General Drugs: Compliance of between 90-100% was evident against 93% November 2012 of standards, compared to 70% in Compliance of 70% or higher was evident against 100% of November standards which is the same as in Controlled Drugs: Compliance of between 90-100% was demonstrated against 80% of standards, compared to 75% in November 2012. Compliance of 70% or higher was demonstrated against 90% of standards, compared to 85% in November. 2.4 Safeguarding Reported separately 2.5 National Patient Safety Agency (NPSA) alerts Overdue alerts: NPSA 2011/PSA001 – Safer spinal (intrathecal) epidural and regional devices. This alert will continue to remain as “ongoing” on the Central Alert System until all of the components we require to safely convert to the new neuraxial devices are available. New alerts: No new alerts have been received. Medical Devices Agency (MDA) alerts Overdue alerts: MDA 096 – Resuable laryngoscope handles All Models, All Manufacturers. Process have been put in place to address this alert but a final solution for ongoing compliance is being discussed currently. MDA 075(r) – Medical devices and medicinal products containing chlorhexidine. Awaiting confirmation from 2 areas that they are compliant. 3.0 Clinical effectiveness 3.1 NICE Quality standards Nothing to report 3.2 Appreciative enquiry Nothing to report 3.3 Mortality See above 4.0 Patient Experience Patient & Staff Safety: Listening into Action • • A guide on good examples of feedback is being developed to send to assist managers via staff communication. A snapshot audit shows that incident and risk issues are being discussed at 70% of staff meetings. There is some concern that some staff say that they do not have team meetings and this will further be addressed through a hot topics questionnaire. Friends and Family Test Survey (Net Promoter) Summary Results Dashboard – January 2013 The Trust continues to achieve above the NPS target of 65 Note: All Trusts have different targets and baselines. Common feature is showing a 10 -point improvement over the year. While the Trust continued to improve its NPS, the survey response rate dropped further. Net Promoter position Resources have now been identified to expand the Patient Experience Team which will enable a more robust and co-ordinated approach to improvements in patient experience and bringing patient experience to the Trust Board. Hospital Site Details Total responses in each category for A&E Department Site code *The Site code is automatically Hospital Site name populated when a Site name is selected 1 - Extremely Likely 2 - Likely 3 - Neither likely or unlikely 4 - Unlikely 5 - Extremely unlikely 6 - Don't Know City Hospital RXK02 Sandwell General Hospital RXK01 55 11 10 8 0 1 5747 85 1.5 38 5 6 4 0 0 3866 53 1.4 Birmingham Midland Eye Centre (Bmec) RXK03 101 8 7 9 1 0 1834 126 6.9 Total 194 24 23 21 1 1 11447 264 2.3 Total Total Number number of Resp responses of rate fo for each people A& A&E eligible depar departme to nt respond Friends & Family Test results for A&E Patient Related Outcome Measures (PROMs) Complaints / PALS 4.2 Complaints Data Complaints: The following table sets out the complaints data for February 2013 with reference to previous months where relevant. MONTH First Complaint type: Complaint type: RECEIVED SENT Link*2 TOTAL contact* Oct 2012 62 First Link*2 TOTAL 19 116 contact* 12 74 97 Nov 2012 68 11 79 113 15 128 Dec 2012 39 5 44 76 17 93 Jan 2013 60 14 74 47 7 54 Feb 2013 70 6 76 56 10 66 *First Contact complaint: where the Trust’s substantive (i.e. initial) response has not yet been made. 2 * Link complaint: the complainant has received the substantive response to their complaint but has returned as th remain dissatisfied/or require additional clarification. Breach cases Some complaints continue to accrue “active” days as they have not yet been concluded and closed. These are generally out of the control of the Trust and as at the time of this report these include: Correction position as at 1 February 2013 was20 cases in breach. The breakdown is as follows: 3 cases where the complaint is progressing to a meeting 2 cases where the complainant is considering next steps 10 cases where the response is at the final stages of the complaints process 5 cases at early stage of the complaints process PALS Issues • • • Contacts and general enquiries: In February 2013 PALS recorded 196 PALS enquiry contacts and 174 general enquiry contacts. In comparison, to January 2013, where we received 196 PALS enquiry contacts and 203 general enquiry contacts. The general informal enquiries are not captured on the PALS database but relate to enquiries taken at the PALS reception desk. Chart A provides a breakdown of the themes identified via PALS contacts in February 2013. The main categories reported during the month of February 2013 were issues relating to: Clinical Treatment PALS received 36 enquiries this month in comparison to 29 issues reported during January 2013. These relate to queries compromising the categories of clinical care, low • • staffing levels, and medicines. In addition, issues relating to a delay in the following: investigations, results, surgery treatment and x-ray/scan. During February 2013 there was reduction in the number of appointment queries where 26 were reported this month, in comparison to 34 enquiries during January 2013. Appointment related enquiries relate to appointments cancelled, delay, notification and time. There has also been a reduction in the number of formal complaint issues which comprise the categories of handling, advice, process, referral and response time from 31 enquiries received this month in comparison to 44 enquiries reported during January 2013. 24th April 2013 Enc 10 Report Topic: Strategic Commissioning & Redesign Subcommittee Report Report From: Dr George Solomon Date: 22nd April 2013 Aim of Report To update the Governing Body on the work of the Strategic Commissioning & Redesign Subcommittee RECOMMENDATIONS The Governing Body is asked to NOTE the contents of this report and ratify decisions undertaken by the SCR. IMPLICATIONS: Financial None Patient & Public Involvement None Healthcare Commissioning None Equality Impact Assessment/Diversity Impact None Engagement (Clinical or Non Clinical) None Legal None Vision and Values None Workforce None Other SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP Report to the Board Subject: Strategic Commissioning & Redesign Subcommittee Date: 22nd April 2013 Author: Lisa Maxfield Remit of Subcommittee The purpose of the Committee is to; • • • provide the Governing Body with assurance that it is meeting the obligations of an effective commissioning organisation ensure effective and efficient delivery of the CCG’s strategic commissioning plan ensure all commissioning intentions; strategically determined or locality derived, are aligned to the strategic commissioning plan Progress last Month The last meeting of the group was in March 2013 The SCR committee received a 6 month evaluation of Sandwell MBC’s Rapid Intervention Team for End of Life. The evaluation was focussed on efficiency - facilitating dying at home and avoiding hospital admission. Cost effectiveness – compared with the costs of alternative services including, hospitals, hospices and Sandwell End of Life Bungalow beds. Qualitative – feedback from carers and professionals who refer to the service. The evaluation was favourably received and the SCR agreed to continue to fund the service from NHS/LA transfer monies if they are available. The SCR agreed to commission the Diabetes Service Specification subject to changes to KPIs. Evaluation of the Black Country LCG Cardiology pilot was presented. SCR agreed that a Cardiology Steering Group be formed to devise and agree a Community Cardiology Specification for the CCG. It was also agreed to extend the Black Country Cardiology pilot for a further three months to enable the steering group to agree future provision options. An evaluation of the AF service was presented to the SCR, this has proved to be very successful. There are significant savings attributable to this service not only monetary but from a prevention and quality of life perspective. The committee agreed to run the same scheme during the winter of 2013/14. An update was given to the SCR regarding the community DVT pathway and progress so far. SCR agreed that oral anticoagulation should be incorporated into the pathway and it was agreed that the Community DVT Pathway Service Specification be presented at the next meeting. The SCR agreed to a GP Incentive Scheme which is to Simplify Tier 1, incorporate investment of time and effort by practices in engaging with CCG/LCG: • Practice representation, each practice nominates a clinical lead and deputy (deputy can be the practice manager) to undertake specific roles to support the delivery CCG and LCG priorities. • Practice attendance at LCG meetings (regular locality meetings and 2 PLTs organised by the locality and CCG events (PLTs and membership events) • Practice regularly reviewing activity and financial information supplied by the CCG • Practice utilising of the designated CCG demand management and risk stratification tools when they become available • Payment 75p per registered patient The SCR received a business case proposal from Vitality Partnership, the SCR agreed with the overall concept but was unable to make a decision on the day and agreed it would write to Vitality Partnership. The SCR agreed in principle to a paper in relation to innovation schemes. The SCR were given an update on the Bungalow Beds that are being procured and agreed to receive an updated position in 2 weeks at the next CBPG. Workplan for Next Month 1. JSNA 2. QIPP Commissioning Intentions 3. NHS 111 4. Termination of pregnancy 5. Diabetes local Incentive Scheme 6. Dermatology Business Case 7. DVT Service Specification 8. Issues for escalation to Board No issues were identified for escalation. Enc 11 SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP FINANCE and PERFORMANCE MEETING Minutes of the meeting held on 25th March 2013 In Meeting Room 2, 4R, Kingston House Attendees: Name Job Title Ian Sykes Julie Jasper James Green Martin Stevens Dr Klair Black Country Commissioning LCG Lay Member – Chair of Audit Committee Chief Finance Officer – SWB CCG Head of Business and Contract Performance – SWB CCG Louise Piper Business Support Apologies: Vijay Bathla Paul Sheldon Chair of SWB CCG Finance and Performance Committee Deputy Chief Finance Officer – SWB CCG Item 1. Subject Welcome and Apologies Ian Sykes chaired in place of Vijay Bathla and welcomed everyone to the meeting. 2. All received apologies were noted as above. Minutes Were presented in draft for approval – these were approved as a true record of the previous meeting Pass to AH for Board 3. Chairs report It was noted that this is the last meeting of the shadow CCG before it is officially recognised as the CCG 4. 1 Finance report Action Enc 11 Item Subject James Green gave an update from the last 11 months of the financial year This year will end in financial balance , with the £7.4m surplus from PCT transferred to CCG which will account for the mandated surplus required for 2013/14 A discussion was undertaken surrounding Innovation funding and how/if it will be allocated in the new financial year. It was agreed that there needed to be standardisation of process for innovation schemes if they are happening in 201314. It was further decided that innovation schemes need to be genuinely innovative, and that evaluation needed to be undertaken in the 2012/13 projects for potential rollouts. 5. Performance report Group reviewed the performance report. It was agreed that a business performance group is to be convened, with a membership of Martin Stevens, Paul Sheldon and Olivia Amartey as the core members then clinicians/officers to be brought in as and when required. The group will report into Finance & Performance Committee. The purpose of this group will be to monitor performance of the CCG, and as an operational group to enhance and drive performance, that Finance &Performance Committee can challenge if required. A&E underperformance was discussed with reference to the Stroke Service, which should divert pressure from City Hospital, this is to be monitored to ensure it is delivering. The increase of the Plastic Surgery service was discussed; in particular there is a specialist in breast reconstruction that has long waiting list as there are of people choosing to see this consultant. 6. The Committee approved the report. Finance report – Proposed budget 2013/14 JG tabled the report which was then reviewed and discussed. The report is based on January draft financial strategy. The scopes of responsibilities were detailed. Available resources reviewed and compared with PCT. Costs and expenditures were reviewed and discussed. The QIPP challenge was outlined, The risks highlighted and reviewed. At present 2 Action Enc 11 Item Subject Action a £15m gap has been identified relating to Specialised Services allocation dedications, we are currently working across CCGs to identify areas as this is an issue across West Midlands. Work is being undertaken to review and identify reductions. No acute contract has been signed as yet, which impacts across CCGs. There is a commitment to resolve but solution not identified as yet. LAT have been made aware of issue and know that contracts unlikely to be signed by Thursday. There is at present a £5m exposure, identified as too high risk to sign off contracts. The possibility of risk sharing across the Midlands was discussed, but was deemed not a possible solution at present. Risks are highlighted at beginning of year – JG to add appendix with further detail analysing risk. The committee approves the report on principle to be passed to Governing Body for further approval. 7. Any Other Business The was no further business to discuss 8. Date and Time of Next Meeting A set pattern is to be established for 2013/14 Next meeting will be provisionally on Monday 22nd April at 1pm to 3pm Kingston House. The group will be canvassed for dates at the May meeting to be provisionally held on the 20th. 3 Enc 12 SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP QUALITY AND SAFETY MEETING Minutes of the meeting held on Monday 11th March 2013 In Meeting Room 4R, Kingston House Present: Richard Nugent (RN) –Independent Committee Member - CCG Claire Parker (CP) – Chief Officer, Quality - CCG Andy Wakeman (AW) – Public Health Lead, Governing Body Alison Hodgson (AH) – Corporate Assurance Manager Liz Walker (LW) – Head of Medicines Optimisation Dr Ayaz Ahmed (AA) – GP Lead – Sandwell Health Alliance Dr Liz England (LE) – GP, Healthworks Noorin Akhtar (NA) – Patient Representative HOBAG Birmingham Link Jonathan Holt (JA) – Clinical Excellence Facilitator Dot Gospel (DG) – Links Management Group/Sandwell Patients Representative In Attendance: Dr Bob Ryder – Diabetes Consultant – Sandwell & West Birmingham NHS Hospital Trust Dr Pia Gupta – Research Fellow – Sandwell & West Birmingham NHS Hospital Trust J Taylor – Temp. Business Support Officer (notes) Apologies: Dr Sam Mukherjee Dr Gwyn Harris Dr Pri Hallan Jane Salter-Scott Eileen Welch Lornay Webley Margot Warner Martin Stevens Emma Bodycote Item Subject Action 1. Apologies As noted above. 2. Declarations of Interest None recorded. 3. Minutes of Last Meeting Minutes of the previous two meetings (08.01.13 and 12.02.13) were confirmed as an accurate record of discussions. 4. Action Register: Updates were recorded as follows: 1 Enc 12 Item Subject Action GP Record Keeping Audit CP reported that the latest GP Record Keeping Audit was to be an AOB agenda item at next Health Forum meeting in order to discuss how to take forward. Safeguarding CP reported that the bi-monthly report was due for the April meeting. Serious Incident Report CP reported that Helen Jones had now left the organisation and that Jonathan Holt would assume temporary responsibility for SI reporting. Updated SUI report had been compiled and was circulated at the meeting (see agenda item below). Emergency Department Update See agenda item below. 111 Update To be removed from report. Risk Register See agenda item below. Items taken out of sequence on agenda: 5. Presentation – Research Study A slide presentation was made by Dr Bob Ryder and Dr Pia Gupta from SWBHT regarding research into a potential new NHS treatment (Endobarrier) which, it was reported, may be beneficial for people who are overweight / have poorly controlled diabetes. Dr Ryder explained that the Endobarrier treatment had been the subject of a multi centre study, tested in a number of different countries and had achieved European CE mark. Research support costs had been achieved via grant and the treatment had been approved by National Institute for Health Research (approved NHS study). Because the study had been undertaken in the NHS, it required NHS treatment costs for which financial support was now being sought from the CCG. Dr Ryder reported that the treatment had been used privately in the UK and it was hoped to now test it in an NHS environment. The treatment was associated with 20% weight loss and 2% reduction in HbAlc and it was highlighted that some patients may be able to come off medications or require less. It was unknown what happens after the initial treatment year however and further research was required therefore to ascertain what happens with combined treatments and to find out how Endobarrier works with regard to devising new treatments. The multi-centre trial had involved Glasgow RI, City Hospital Birmingham (Dr Ryder Chief Investigator) and Kings College Hospital London. It was hoped to 2 Enc 12 Item Subject Action recruit 72 patients – 24 in each centre. Trying to target patients who currently have access to best therapies available currently apart from surgery. (Inclusion criteria – HbAIc > 7.5%, BMI > 35). Exclusion criteria related mostly to issues of safety (anti-coag/bleeding etc). Treatment arms would involve three different patient groups: a. Patients who would continue on drug treatment but on higher dose – within licence (not in wide use in UK) b. Patients who would have device inserted but would discontinue drug c. Patients who would have device inserted but would continue on drug It was proposed that comparisons would be made within b. and c. patient groups. Discussion took place re cost comparisons: National tariff £7k for bariatric surgery (severe complications exist here however, also non-reversible treatment). Endobarrier device cost approx £3.2k (£1600 each for putting in and taking out, reversible treatment). It was highlighted that it was also important to ensure safety assessments were carried out properly (abdominal x-ray and full blood count in subsequent follow up visits). Manufacturers were also recommending that all patients that had device, proton pump inhibitor be fitted for a year. Therapy for first patient group would be stepped up with 1.8mg dose – extra costs associated for these patients extra costs for those eight patients would be approx. £7600. Overall costs for 24 patients equate to £64k. Figure does not include cost savings associated with patient group b. Significant cost saving over £7k. It was commented that drop-out rates would be measured. Patient primary outcome would be based on the differences in the three patient groups, taking drop-out rates into account; end point calculated at year after device removal. Queries were raised with regard to offering the patient control group Endobarrier treatment and whether the treatment involved any complications or side effects. It was advised that UK-wide coverage in NHS was being attempted and that the whole treatment protocol had been assessed in depth and involved much patient and public involvement and generated much patient interest. Side-effects included temporary nausea/abdominal pain (patients would have been warned about this). 500 patients had been trialled in Netherlands, resulting in two patients experiencing complications for bleeding for which device needed to be removed. Two out of 100 had experienced pancreatitis but 3 Enc 12 Item Subject were fine after having the device removed. The query was raised with regard to differences between Endobarrier and gastric balloon. It was advised that the gastric balloon was inserted into the stomach but not the intestine to give patients the feeling of increased fullness but that the treatment had not performed well in clinical trials and was deemed to be ineffective. The Endobarrier was designed with the aim of mimicking bariatric surgery, by-passing the intestine (not touching the stomach) and producing changes in gut hormones. It was proposed that two gastroenterologists would be trained re Endobarrier treatment (one of which would always be around) and patients would be provided with contact telephone numbers if the devices were required to be removed quickly. Discussion took place with regard to exit costs and whether these related to drug (Liraglutide) costs only. Dr Ryan advised that if a patient had lost three stone on a 1.8mg dose, then a reduced dose of 1.2mg should be trialled to see if that patient could maintain their weight on that reduced dose. If they were unable to do this however, a special on-line request could then be raised for that particular patient. A question was raised about the 1.8mg dose in the control group – the response was to give the group something good for being part of the trial. The query was raised as to why the trials did not include the use of Exenetide. Dr Ryan advised that an ongoing nationwide audit on Liraglutide was underway in real clinical practice from which data was being collected. The patients going into the Endobarrier trial would be from the audit as six months of data would be available to demonstrate that those patients had plateau’d, providing baseline therefore before fitting the Endobarrier. With regard to queries relating to patient selection, it was advised that patients would come from within the nationwide audit who still had the criteria of being poorly controlled/BMI in excess of 35. It would be up to clinicians who have such patients who meet criteria to put them forward. Patients would also be referred from diabetic and obesity clinics. The query was raised as to whether CCG clinicians would have an opportunity to nominate patients to go into the trial. It was advised that those patients would have to have been in the nationwide audit for six months. Discussion took place with regard to funding being requested (£64k) and commencement of CCG governance process. Dr Ryan advised that as the Endobarrier treatment had been the subject of an NHHR study, the treatment had to be undertaken within an NHS endoscopy suite. CP explained that currently such funding sat within the Public Health section of the PCT but it was not clear where research funding would sit from 1st April. CP 4 Action Enc 12 Item Subject Action suggested because of this situation there was the need to take the request to the Strategic Commissioning & Redesign Group to identify research funding streams/CCG priorities. ACTION: Funding request to be agenda item at next SCRG meeting. CP to feedback information from that meeting to Dr Ryan/discuss next steps that need to be taken from a commissioner perspective. CP 6. Quality Report SWBH: Outbreaks: AH reported that a report had recently been submitted to the S&WB meeting following recent CQRM visits which had included an update on outbreaks following ward closures; debriefing session bulleted learning highlights were contained within the report. Mortality: AH referred to Roger Stedman report on mortality highlighting the significant differences reported in mortality rates between Sandwell and City Hospitals. It was reported that Sandwell & West Birmingham Trust had a lower mortality rate than any of the top 15 chosen for special review following the Francis Report. Sandwell General Hospital on its own however had a higher rate and fell within the top ten in the country for mortality. This situation is concerning and as a result more in-depth information and reporting has been requested. CP commented that she would be would be looking to replicate national “deep dive” situation at Dudley Group within Sandwell also. She added that Roger Stedman was scheduled to meet with Dudley Group, reporting from which would be picked up via the CQRM process. AH reported that mortality reviews are continuing. Francis Report: AH reported that a summary of 290 recommendations had been provided to the Trust for initial response and that in order to progress/take forward, the CCG Governing body and SWBH Trust Board would benefit from taking a joint approach. Event to be organised. Dementia: AH advised that Rachel Overfield had provided an update on how the organisation was looking to improve dementia patient experience and work being undertaken with the multi-agency/multi-professional steering group. Key areas for progression included staff training and improvements to the environment, End of Life care, activities and information. CP provided information on Black Country Partnership Lighthouse Project and Sandwell & West Birmingham project around improving ward environments for patients with dementia. She added that both Trusts had been shortlisted for a grant and had now to go through the next process for approval. 5 Enc 12 Item Subject BCPFT: Learning and Development: AH reported that following the mandatory training review across Black Country Partnership, the process had been revamped to enable core mandatory training to be undertaken in one day. Lots of good reviews had been reported, attendance had increased with people booking in to training in advance; managers supporting fully. NICE Guidance and Quality Standards AH advised that a really good report had been received around infection prevention and control. (Data contained within report for information). She added that complaints were still be monitored and no breaches had been reported. AH/CP provided an overview of the revised/improved complaints procedure following advent of Francis Report. AH advised that consideration was being given to looking at devolving complaints down to clinical areas but highlighted the need to ensure priorities remain however in responding to complaints. AH provided clarification on National Patient Safety Alerts advising that national alerts were received in relation to services/medical devices/medication etc which are then disseminated to providers of services who then have to respond to say that they have taken the appropriate response against that alert. Enables trend analysis nationally re all sorts of clinical incidents. Discussion took place with regard to the format of the quality report; CP commented that work would continue to develop the report in order to streamline/make it more user-friendly. SUI Report JH provided an overview of the SUI report highlighting incidents around ward closures and around grade 3 pressure ulcers reported by SWBHT. Also picked up were issues around delays in relation to the notification process. (Report received was up to date as of 07.03.13). CP commented on the need to get closure on SIs within 45 days. She added that much work had been undertaken to ensure as many as possible were closed prior to Helen Jones’ departure. CP added that a number of grade 3 pressure ulcer SIs had been closed down and that most of the other SIs related to the second outbreaks of Norovirus and ward closures. SIs were also being looked at by the Infection Prevention Team and being picked up on delayed reporting/ through CQRM. CP advised that issue with Black Country would be raised at the next Mental Health meeting. CP reported that it would be possible to make comparisons re SIs on the new 6 Action Enc 12 Item Subject Action st Datix system from 1 April. She added that once Helen’s replacement was in post, it would be possible to report more robustly. ACTION: J Holt to provide JH report re month on month changes. CP provided an overview of the STEIS national web-based SI reporting system. 7. Policy Ratification No policies were presented for ratification at this meeting. CP suggested that it would be beneficial for patient representatives to visit the virtual patient group in order to be able to comment on policies from a patient perspective. It was reported that once ratified, policies are updated to CCG website. 8. Exception Reports CP reported that a skeleton action plan had been started in response to Francis report. CP will begin to look at this in themes initially around Complaints/ Concerns/Datix system reporting as this formed major part of action plan. ACTION: Draft Action Plan – ongoing agenda item. 8.1 Emergency Department CP reported ongoing issues relating to performance at the Emergency Departments at both sites. She added that quality and safety had improved hugely and as a result planned to present incident reporting relating to ED as there had been no serious incidents since summer last year. CP expressed concerns however in that low level incident reporting was also coming down. This was not the case however as green and yellow reporting was increasing. (Good reporting culture). Red incident report was going down. CP commented that this demonstrated even though going through reporting issues, situation is reported as safe. CP reported that both ED’s had been put into special measures by the Trust purely relating to Q&S issues picked up last summer. She added that at the recent Assurance Group meeting however it had been agreed that both EDs would come out of special measures but that performance reporting would continue. Discussion took place with regard to recruitment plans for the hospital. Approval for funding was received in January at SWBH Trust Board for extra middle grade doctors and nursing staff and an additional Registrar for ED. CP reported that the action plan received appeared to be “very corporate” and did not reflect what was happening at the “coal face”. CP had a meeting scheduled with the new ED project manager to go through the action plan to 7 Enc 12 Item Subject look at actions relevant only to ED. General discussion took place re Acute Trust/intermediate care beds/message going out to public about not turning up at A&E. In relation to a query raised by DG regarding doctors going into hospital A&E Departments, CP reported that GPs had been in place at Sandwell Hospital for the previous three months and for just 2-3 weeks at City Hospital and that the situation was currently under review. DG raised concerns about the non-education of people in relation to patient queues. Further discussion ensued with regard to Walk-in centres; CP advised that this situation was also currently under review and that evaluation was awaited. 8.2 Screening Programmes ACTION: Remove from agenda – screening programmes no longer CCG responsibility. Programmes commissioned by NCB. In view of above, RN suggested that it would be beneficial for a summary to be produced in relation to the new areas of responsibility relating to screening. 9. Infection Prevention No updated report available. CP reported a further number of ward closures around Norovirus. Sandwell and City hospitals had been badly hit; some of that being a reflection of the number of agency nurses in use, pulling people in who have worked on both infected and non-infected wards and moving around when they shouldn’t. This has been recognised as an issue. Auditing still meets required standard. CP also reported a further outbreak of VRE - particularly prevalent amongst community groups. CP trying to bottom out with Sandwell Public Health. 10. Datix AH provided update re Datix advising that the system was currently being “built” to CCG specification. The incidents reporting side of this was almost complete, forms/policy links would be available. CCG will be contacting practices with regard to organising installation and training. Practice reports will be available (utilising live dashboard). Next steps will be complaints and risk management. It was suggested that a live demonstration could be made at the next Q&S Committee meeting. CP highlighted that it would also be possible to report on concerns as well as complaints, balanced with compliments. She added that a customer care team would be in place to enable reporting of informal complaints/concerns and that it would be possible to analyse emerging trends and issues/action accordingly. 8 Action Enc 12 Item 11. Subject Action Issues were raised with regard to concern reporting protocols especially in relation to individuals when they are not aware of the concerns being raised. ACTION: Emerging information/information governance situation to be CP/ AH reviewed. Equality & Diversity Quarterly report due for May meeting. 12. Risk Register AH reported that the risk register had been issued several times and that it had been raised as a risk that the report was not being completed. She added that the Finance Team had risks to be included, together with the Strategic Commissioning Redesign team. The report was therefore starting to get populated and the Audit Committee had asked for the Q&S committee to look at the risks and give assurances that they are being appropriately recorded and appropriate controls and actions are in place. AH reported that all meeting Chairs had been requested to include risk register as an agenda item at all meetings. AH asked if there were any risks that had been missed and needed to be included from a Q&S perspective. RN suggested that clarification about responsibility within new structure should be included as a risk. AW reported differences in the PLCV commissioning policies in existence. ACTION: Risk Register to remain as standard agenda item. 13. Clinical Audit Proposal CP enquired if any further consideration had been made around Diane Lynch proposal around delivering a programme of clinical audit for the CCG. She added that it was not clear where audit sits from a CCG point of view currently but that there was some value in having a programme with regard to bigger pieces of audit work to improve quality - situation requires clarification. CP enquired if Clinical Audit should remain as an agenda item for the C&S Committee or transfer to Primary Care Quality Committee. CP suggested chosing four audits per year across CCG and linking with Francis Report action plan and Datix trend information also. ACTION: Clinical Audit Proposal to remain as agenda item. 14. Quality Structure Update CP reported that recruitment was underway currently for six posts within 9 Enc 12 Item 15. Subject Quality. Community Nursing Specification – Update Item deferred to next meeting. 16. Primary Care Quality Dashboard Item removed from agenda. 17. Any Other Business Medicines Optimisation Team Strategic and Operational Framework April 2013March 2014. Liz Walker provided an overview of the above report which detailed the operating framework to be utilised by the Medicines Optimisation Team in relation to the key aims and vision for the team over the forthcoming year. The document would be used to focus the team in order to reduce HARMS associated with medicines use, improve patient experience and reduce health inequalities in relation to medicine taking. The team would also support prescribers by advising on safe and best practice, forming part of the wider QIPP agenda by achieving cost effective medicines management. 18. Date of Next Meeting Tuesday, 9th April 2013 – Boardroom, 2F – Kingston House PLEASE NOTE THAT ALL FUTURE QUALITY AND SAFETY COMMITTEE MEETINGS WILL COMMENCE AT 13:00-15:00. 10 Action Enc 13 SCR Meeting : 28th February 2013 Attendance: George Solomon Olivia Amartey Paul Sheldon Richard Nugent Basil Andreou Arun Saini Mark Foullerton Pri Hallam Ian Walton Paul Russell Carla Evans Sirjit Bath Mohammad Khalil Angela Poulton Apologies: Lisa Maxfield Jon Dicken Manir Aslam Jayne Salter-Scott Simon Butler Claire Parker Dr Chawla Declarations of Interest: GP incentive scheme and Diabetes incentive scheme (all GPS) Previous Minutes: Add Pri Hallam in Attendance Various spelling errors noted Actions JSNA Paper - JSNA Item Decision Action JSNA Andy Wakeman to JSNA and Health & Wellbeing produce a paper on Strategy paper to be produced JSNA and for Health & Wellbeing Strategy for clarity Owner Andy Wakeman Enc 13 111 Item 7: Tier 3 weight Management service Risks need to be highlighted in reports in future for the Risk Register Basil Andreou GP from Partnerships Committee to be identified to join the Sandwell Children and Families Obesity Group as representative Contract Evaluation All Questions to be clarified for end of April Paul Stevens 9.2 Integrated Paper not presented commissioning of sexual health 2013 9.3 Diabetes Group note the report, further detail to be presented in March. Ratification to be sought at Board Carla Evans Enc 13 9.4 Maternity Spec and KPI Decision to work with the Wirral to develop a similar model for SWB CCG Carla Evans AQP specification for community Midwifery to be undertaken Local KPIs to be included in contract for 12-13 Noted the update to the two workstreams 9.5 Bungalow Beds 9.6 Community Nursing – Service specification Deferred decision George Solomon & Paul Sheldon to work up the options in order to get consensus by email George Solomon Paul Sheldon V3 to go to consultation Group to review the document and provide feedback to Angela Poulton Angela Poulton to forward the document to Mark Foulerton Reminder from George Solomon that this is confidential and not to be shared outside this group Incentive Scheme Move to two tier model – paper to be written for discussion at next Directors Group Support for 50p in tier 1 Mohammad Khalli £1 for tier two AOB – Paul Sheldon – Murray Hall reduction in income Charity is now untenable until an action plan is created. They can continue in a reduced capacity once they have transitioned – proposal to fund the transition period through PCT money – currently provide valuable community service. Group agrees in principle, but service delivery needs to be agreed. Enc 13 Enc 13 Enc 14 SANDWELL AND WEST BIRMINGHAM CLINICAL COMMISSIONING GROUP SANDWELL HEALTH ALLIANCE L.C.C. BOARD MEETING Minutes of the Meeting held on Tuesday 26th February 2013, 1.00-4.00pm @ Oakwood Surgery, Izons Road, West Bromwich Attendees: Dr B Andreou (BA) Dr P Hallan (PH) Dr A Ahmed (AA) Dr S Chawla (SC) Dr P Klair (PK) Dr D Manivasagam (DM) Deska Howe (DH) Laura Mainwaring (LM) Angela Poulton (AP) Hannah Peach (HP) Chair Vice-Chair Quality & Safety GP Lead Strategic Commissioning & Redesign GP Lead Finance & Performance GP Lead Partnerships GP Lead Patient Representative Finance Management Lead, SWB CCG Senior Commissioning Manager, SWB CCG Prescribing Lead In Attendance: Andy Williams Accountable Officer, SWB CCG Apologies: None Item 1.0 Subject Welcome and Apologies 1.1 BA welcomed Andy Williams. 1.2 No apologies were given. 2.0 Declarations of Interest 2.1 All GPs in relation to Dr First and the Respiratory Pilot. 3.0 Minutes of Previous Meeting The Minutes were declared a true and accurate account of the previous meeting. 3.1 Matters Arising None. 1 Enc 14 3.2 Progress Against Actions From meeting 23/10/12 3.2.1 6.8 LM to provide Lymphodema performance information before the next Board meeting. 3.2.2 12.3.1 AP has contacted PK about taking on the SHA Demand Management locality lead role. PK to find out more in relation to what is involved and assess whether the role can be fulfilled given his finance & performance lead commitments. 20/11/12 3.2.3 3.2.4 3.3.7 AA reported that he had intended to raise the issue of X-ray reporting at Sandwell Hospital under AOB at the last Quality & Safety Committee but the Francis Report led to the need to take this to the next meeting - action carried forward. . 5.2 PK confirmed that the locality referral report for 2012/13 had been sent out by Laura Mainwaring. 22/01/13 2 3.2.5 4.2.4 PH confirmed that he had been appointed as Clinical Lead for Community Nursing. Version 3 of the revised service specification should be completed by tomorrow for presentation to SCR to enable patient engagement to commence. An options appraisal paper has been requested by Directors to be taken to March Governing Body to confirm the preferred procurement route. GP engagement is required but the approach to this is still being developed as given the commitment to put the service out to tender there is the need to manage the conflicts of interest (as GPs could potentially provide) with the need to enable wider GP input into the redesign work and specification. There remains the concern that the specification has been developed to date without nursing input which needs to be addressed. PH stated that it had been agreed to limit distribution of the latest draft of the specification to Directors and in strictest confidence – action closed. 3.2.6 5.2.6 PK/LM confirmed that the outpatient referral data had been re-sent as some practices had difficulty using the pivot tables – action closed. 7.3 Action carried forward. MD to send patient details where he had been asked to prescribe by the acute Trust to HP. 3.2.7 7.4 Steering Group agenda item to advise members that instances where pharmaceutical companies were contacting GPs directly need to be reported to Medicines Management. 3.2.8 8.9 Item was discussed at the Planning & Delivery meeting on 19th February and is on this meeting’s agenda. Enc 14 3.2.9 11.1.4 EC sent AP a report just before the meeting so there has been no time to review this. It was agreed that this will be carried over to the following meeting. 3.2.10 11.1.5 Respiratory pilot later on the agenda for this meeting. 3 4.0 Chair/Vice Chairs Report 4.1 PH reported CSU and future ICT provision had been discussed at Directors meetings during February. The CSU are providing ICT support to the CCG and Graham Westgate is the lead. 4.2 The Francis Report had been discussed at Directors given the 290 recommendations it contained. Key headlines include GPs having a bigger monitoring role on providers, the establishment of minimum standards of care and the need for changes in the both the culture of care and quality of provision. 4.3 PH reported that locally 111 had been red rated, resulting in the soft launch being delayed until the 12th March. 4.4 At Directors there has been a demonstration of the Map of Medicine referral management tool. It integrates with current systems, will integrate with EMIS in October and will include all local pathways. It will also help GPs with their validation. PH explained that the way it works is that each time a problem is entered on to the system it automatically finds the appropriate patient pathway. The tool will audit and record all information that has been viewed. Discussions are underway regarding practices potentially being incentivised to use it 4.5 Discussions at Directors also focussed upon the problems in the urgent care system. Andy W stated that the challenges in A&E were due to a combination of factors including problems with bed flow, in part relating to Local Authority issues, the ward closures owing to Norovirus at Sandwell and City sites, and leadership within the Trust. 4.6 BA reported that the CCG Constitution has been to both LMCs twice. 4.7 It was reported that a paper on the management support organisational structure had been presented and discussed at Directors. The restructure was required due to the CCG taking on more responsibilities than originally planned e.g. WMAS commissioning lead, safeguarding, continuing healthcare, and had resulted in the creation of some new posts and the re-banding of some existing posts. 4.8 AW stated that in terms of change to internal management structure, the CCG has taken on a number of additional roles: the regional Lead Commissioner for Urgent Care, West Midlands Ambulance Service, 111, and Stroke. In addition there has been a change to the amount of work received from CSU and that this CCG is going to deliver itself. It is the combination of these two things, as well as disaggregating shared commissioning arrangements with the Council regarding Mental Health and Learning Disabilities that required a major change to the structure of the Enc 14 organisation. This has meant relocation from Floor 2F to 4R in Kingston House, and an increase in the number of directly employed people from 44 to 92. Overall this has resulted in a considerable saving against the management costs budget (£1m), with a total of £2m saved as a consequence of not relying on other organisations. The Directors considered the proposals and agreed them. In response to a question, Andy W clarified that for the regional posts commission on behalf of the West Midlands and the CCG pays a proportion of the cost, with the other CCGs we work with contributing to the total cost. However, this CCG has to take on the respective increased responsibility and accountability. 4 4.9 PH stated that he raised some concerns at the Directors Meeting regarding the re-banding, but having gone through the reasons for the changes and the need to ‘match and slot’ staff to jobs he was now reassured. 4.10 Andy W confirmed that QOF/GP appraisals (as part of primary care contracting) is the responsibility of the NCB. CCG can play a role in supporting but the resource to support has gone to the NCB. The CCG and NCB are both operating with much smaller staff numbers. 5.0 Finance and Performance Report 5.1 PK reported that A&E is not meeting its 4 hour target despite investment for winter pressures. Discussions were underway regarding the way the service is managed and the option to use fines. 5.2 The 18 week waits for plastics and Trauma & Orthopaedics is not being met and this needs tackling. Fines can be applied amounting to 2% of the contract value and it is the decision of Directors whether to enforce this. There was a discussion about reinvestment with a plan of how this will be delivered in the future. 5.3 The savings on Medicines Management were originally thought to go back to the Treasury but at least 60% goes back to CCGs. The Strategic Health Authority has asked for between £6-10m in reserve to act as a buffer. 5.4 Practice budgets are a concern of GPs and the right to challenge the approach to budget setting was being sought. The Finance and Performance Committee are seeking to clarify LCG budgets for 2013/14. There are two formulas that can be used, one is historical budgets (what they always had) or fair share (based on population and disease prevalence). The general agreement was that there will be winners and losers whether either formula is used and it is therefore being proposed that a hybrid solution is used so that everyone feels that they are getting a reasonable budget for their practice. Once the budget by practice is established the plan is to create a league table showing budget management performance (similar to referrals). The reason for this is for the CCG to identify outliers in addition to those practices that are spending wisely. 5.5 PH raised a question relating to the proposed hybrid formula for budget setting. He explained that it was his understanding that there had been a commitment to move practice budgets to be established based upon fair shares. If this is the case, there is the question regarding whether hybrid formula would change every year to account for this. PK replied that for the last 3-4 years Enc 14 there has been a move towards fair shares and then it went back to being set on a historical basis. The proposed formula takes account of both historical and fair shares. LM stated that the budget needs to be managed as with fair shares some localities do not spend and some will overspend but the approach to it needs to be sorted to ensure that it is fair. PH responded stating his concern that SHA currently under spend but if the budgeting formula is changed and the locality then reports overspending, it could appear that the SHA is performing badly. 5.6 PK explained that it was suggested that the formula is taken to the LCGs to ask their view but the fear is that there will be five different views. Each LCG will go for the one that it will benefit from, so there will need to be approach needs to take account of the different patterns of referral. The formula used needs to address this and ensure fair allocations to practices. BA stated that we are acting as CCG and not individual practices when sharing the risk. 5.7 PK reported that in relation to Outpatient referrals, practices had been sent their information and that the aim was to increase awareness of the different pattern of referrals across the locality. Practices will conduct a “deep-dive” exercise and PK will discuss performance with them to see where improvements can be made. ACTION: PK to bring back a report in relation to outpatient referrals performance 12/13 to a future Board meeting. 5.8 In relation to contract negotiations, LM reported that the Finance allocation is £606m and distributed a document setting out our responsibilities. There is a QUIP challenge £15m and until contract negotiations are concluded the CCG does not know the extent to which this will be achieved. 5.9 LM reported on the new MICS system which contains finance and activity information, and allows comparisons to be made between practices. LM advised that it will now be rolled out to all localities and it will be up to each locality to decide how they want to be trained on this. Options include organising sessions that GPs can choose to attend or 1:1 training. All finance information will now be accessible via MICS. AP stated the Margaret Holden (Dr Patel & partners) has already been trained on this. It was agreed that DM would be trained to use the system and with a GP and Practice Manager trained the decision could be taken back to the Steering Group. ACTION: MD to organise training on MICS. The decision regarding how to roll out training on MICS in the locality to be taken to a future Steering Group meeting (AP). 5 5.10 LM stated that there is currently an under spend of £1.9m. 5.11 In relation to 12/13 innovation funding, AP stated that she has not received all of the Funding Agreements for approved schemes and corresponding invoices with supporting data. Invoices are not authorised in the absence of a signed funding agreement. 5.12 BA asked about the engagement monies. LM replied that this was originally set at £1.50 (2 x 75p) per patient per practice and there was a proposed increase to £3.00. The incentive scheme did not Enc 14 go ahead and the second 75 pence will not be paid as no targets were set. BA stated that Practices had been led to believe that they would receive £1.50. AW stated there are no plans to pay any more out and there is no incentive scheme this year. Initially the second 75 pence was in the management costs allowance, but when the investment monies were considered, the decision was taken to defer the incentive scheme. The second 75 pence was transferred to the Innovation Fund. Action: AW to liaise with JG and send a communication to LCGs. 6.0 6.1 Quality & Safety Report A Quality and Safety meeting was held on the second Tuesday of the month and majority of the meeting was taken up discussing the Francis Report. It contains 290 recommendations. The key points were: • The appalling and unnecessary suffering of patients • Corporate finance put before patient care • Basic standards of care not observed, including lack of fluids, patients being left unwashed and unfed, filthy conditions, medication not issued, patients being discharged without regard to welfare and focus on Foundation Trust status. The system failed at every level to take action in regard to complaints and Local Medical Committee did not know till too late. • SHA did not put patient safety and wellbeing at forefront. The commissioner didn’t test healthcare adequately etc. The Francis Report Recommendations included: • Clearly understood and fundamental standards which should be defined by what patients and the public expect and what healthcare professionals believe can be delivered. • Openness, transparency and candour throughout the system. A duty of candour and statute should be imposed on all NHS staff. The deliberate obstruction of this duty should be a criminal offence. • Improved support of compassionate caring. No member of staff should have hands on care without being properly trained and registered. • There should be a new registration status for nurses. • There should be strong patient centred leadership • The public should be entitled to see leaders held to account. • There should be a common code of ethics and conduct. • Patients should have access to useful accurate and relevant information and leaders should be able to demonstrate compliance. • False representation should be a criminal offense AA stated that CP would be reporting how the recommendations are to be implemented at a future Quality & Safety meeting. 6.2 6 A group of members carried out a quality spot check at Sandwell on wards Newton 5 and Lyndon 4. They were happy with what they found. Enc 14 6.3 AA informed the Committee that for quarter 3 there were 53 complaints, 30% received by PALS, 30% by phone and 18% by letter. 9% were by email, via an MP and in person. A breakdown of complaints by service provider showed that 62% was concerning GPs, 9% was concerning Out of Hours Service and 9% concerning SWBH. Approximately two thirds were against GP practices and this was comparable with the previous quarter. 20% were against dentists/pharmacists. 6.4 There was a presentation regarding proposed support to help with audits in GP practices at a cost of £93K. AA and Claire Parker were in favour but HoB GPs were not as they undertake audits themselves. It was argued that the investment would enhance the quality of audits. ACTION: AA to report back whether the proposal was approved at the next Board meeting. 7 6.5 DH stated that there are many lessons to learn on how we commission acute and other care. There are issues of performance that come to the LCG. We need to highlight concerns and actions, and decide how use Jayne Salter Scott’s team to capture real patient experience. The CQC are capturing patient experience when using NHS secondary and primary care services but what this tells us is often different to the perspective of patients. There is the opportunity to look at way services delivered, how engage and raise standards. 7.0 Strategic Commissioning & Redesign Report 7.1 PH provided an update of the content of the previous Business Planning meeting of SCR. A number of business cases were presented for information and debate: 7.2 BNP testing for Heart Failure: Dr Berg presented a business case for this test that prevents referrals. The business case has been deferred as pathology services are subject to open procurement. PK stated that Sandwell used to provide the service but it was decommissioned previously. BA stated there was always a dispute between Cardiologists and Biochemists about the reliability and it was expensive. He asked if there was any consultation with Cardiologists in developing the business case. 7.3 Gynaecology: The community gynaecology service has returned to a hybrid service and the uptake was better. The only problem was that some of the Choose and Book Service was going straight to the Trust and not to community service so Choose and Book has been suspended for Gynaecology. 7.4 Faecal Incontinence Nurse: Dr Cruickshank, Gastroenterologist presented the case for a pilot scheme for a faecal incontinence nurse. PH stated that 2-10% of the population suffer with it and it tends to result in a referral. It was decided to accept the business case as it would save money and would be better for patients 7.5 PH reported that there was quite a big discussion regarding Estates. SPCT had 6 legacy schemes and three are now a priority as GPs are in buildings where the lease is about to expire. The decision was to take three schemes forward and other three will be looked at by another group set up by George. A seventh scheme in Great Barr was not listed. Enc 14 ACTION: PH is to confirm which three legacy estate schemes in primary care are being taken forward at the next Committee meeting. 7.6 PH reported that SCR had considered the IBS evaluation and decided to cease this service. The decision was also taken to decommission the Rowley Regis Hospital bath service. An engagement event with the day hospital is underway. 7.7 The work on the end of life bungalows work still underway and will be taken to the next SCR meeting. These are for terminally ill patients who can no longer to be looked after at home. There is a consultant on call and nursing cover. There is an issue around the bungalows having only 50% occupancy which makes them expensive. 7.8 In relation to the provision of religious circumcisions, BA stated that there a policy meeting in relation to procedures of limited clinical value last Friday, and religious circumcision was one of them. As there is a discrepancy in service provision in Sandwell and Birmingham it was decided that there should be a joint review joint review. There was no Birmingham representative present. The next meeting is March 16th. The Group is looking at all procedures and impact assessment will have to be done. 7.9 Other SCR decisions included an extra £3K has been agreed for the Handsworth Medical Centre and funding to support the overspend of £49K by Crossroads and an additional £20K to support the service until yearend. 7.10 There is a plan to deliver IV diuretic therapy in the patients’ home. This has already been given to some of the Sandwell patients but the plan is for it to be commissioned across the entire CCG. 7.11 Mental Health proposals by SCR were presented and although felt to be very good owing to limited time to use the Innovation Fund (ending March) were not supported other than the training element. 7.12 DH stated that there is an issue around the approval process of Innovation Fund business cases and the need for the lessons learnt to be used to plan future processes to use development funds. 8.0 Partnerships 8.1 8 DM stated that there had been no further meetings since the last Steering Group Meeting but there was a meeting regarding Diversity and Equality. One area that was discussed was in regards to genital mutilation. Saba has sent an email to all the practices. It was suggested that this issue be given a twenty minute slot in one of the Steering Group Meetings to discuss as a potential PLT item. 9.0 Your Partnership for Health Outpatient Proposal 9.1 This came from Business Planning and then through SCR. It was presented by Simon Mitchell and it Enc 14 was a proposal to move some activity from Secondary Care services to Community for two Practices, one in Black Country and one in Healthworks. SCR supported the scheme. It was going through as a PCT legacy. LM asked if the service should be tendered as anyone can deliver the service. AW explained that the organisation does not need to tender to test concepts. It was agreed the facts needed to be understood. ACTION: PH to take YPH Outpatient Proposal back to SCR to emphasise Board concerns regarding process for the scheme going forward. 10.0 Respiratory Pilot 10.1 AP stated that it was agreed at the last Steering Group that the Board wanted to discuss the next steps in response to the mid-term evaluation report presented by Elaine Cook. The report indicates that Elaine spent six months at two sessions per week assessing what the level of education and qualifications are supporting COPD and asthma in the practice according to a selfdeveloped scoring mechanism. Training provision has started but only relatively recently. Issues raised in the report were: • • • 9 Engagement/access issues with some practices – one practice has declined to participate Insufficient time to deliver the project, largely owing to no administrative support There will still be some training that would need to be delivered within the LCG that will fall beyond the end of the pilot. 10.2 AP stated that she met with Dr Haque and Elaine on 6th February and they discussed the need to share the scoring tool developed and to agree the minimum level of competence the pilot is aiming to achieve across the LCG. Once the minimum level is agreed between Dr Haque and Elaine, an assessment is required of the training needed across the LCG compared to the forward schedule to the end of July. If there remains a gap, the Board will need to decide whether the training delivered for the duration of the project needs to aim for a lower minimum standard or how the remaining training might be delivered. 10.3 Discussion followed regarding concerns that a business case was put forward with an associated level of funding to deliver a level of education in Primary Care and that now there is the potential for a further business case to be submitted to enable the outstanding training to be delivered. DH raised the issue of the significant time that had been taken to assess the practices and identify training needs versus time actually delivering the training required. He stated that it is a lesson learnt in terms of ensuring that members submit a realistic budget when future opportunities arise to use development funding and the need for the LCG to pay for agreed outcomes and not activities. 10.4 PK stated that he was concerned about the approach taken as in his practice’s experience the score had been attributed via a phone call as far as he was aware. PH asked how the shortfall in money had occurred. AP replied that Elaine had stated at the Steering Group that a major reason why she felt there was insufficient resource to deliver the pilot was owing to her having no administrative resource. It was agreed that for the next meeting the Board will require details of how much money has been spent so far, the scoring mechanism, details of the minimum level all Enc 14 Practices should be achieving, an assessment of how large the gap in training will be. ACTION: AP to circulate the Respiratory Pilot status information prior to the next meeting. 11.0 Dr First Evaluation Report 11.1 The evaluation report is currently in draft form but the cost-benefit analysis has some outstanding work to be undertaken. AP reported that GPs like it, were able to implement it quickly and have sustained delivery. A current issue is that the detail behind how the £2K pump prime budget was used, as per the agreement, is not currently available. 29 practices participated. 11.2 The patient survey feedback required updating as two more Practices have submitted surveys. There is generally positive support although there are issues around patients not knowing about the service until the point where they actually use it. AP reported that the analysis of the survey results showed that 13% of respondents stated that if they had not been able to speak to the doctor or see the doctor through the Dr First scheme they would have gone to A & E. This indicates that the pilot may have contributed to reducing the size of the increase in demand for A&E being experienced. 11.3 AP reported that there was a discussion regarding its helpfulness from a Primary Care point of view as a patient can be assessed over the telephone and anecdotally people are saying tht it can be quicker. ACTIONS: AP to work with LM to complete the cost/benefit analysis and finalise the report In Liz Green’s absence. AP to send letter to practices requiring them to provide information on how they spent the £2K allocation or the money will have to be returned. 12.0 LCG Protected Learning Time 12.1 AP requested that this item be deferred to the next meeting as Claire Parker was advising the Senior Commissioning Managers of the decisions taken regarding locality PLTs at a meeting scheduled on 11th March. ACTION: AP to ensure LCG PLT an agenda item for next Committee meeting. 13.0 LCG Engagement 13.1 AP advised the group that they should have received a list of meeting dates and asked if they were still happy to go ahead with the scheduled meetings during 2013/14. The dates were agreed and will be circulated to members. 13.2 AP reported that the meeting room at Oakwood costs in the region of £30.00 per meeting plus hospitality costs and asked the group if they wished to continue to use this venue. It was suggested that the room may now be too small for the Steering Group Meeting. AP said that if the venue of the Steering Group was changed it was likely to cost more. The consensus of the group was that Oakwood was fine for most meetings, but to look at changing the venue for the Steering Group Meeting. BA offered a meeting room in Oldbury Health Centre for Steering Group meetings 10 Enc 14 at no charge. ACTION: AP to obtain costing of alternative venues for Steering Group meetings and bring back to the next meeting. 13.3 14.0 AP reported that Elaine Cook had sent an email to BA asking if Practice Nurses should be more involved in meetings. It was suggested that they are invited to join the Practice Managers Group or the Steering Group. AP asked the Committee’s view regarding having a nurse representative attend these meetings. It was felt that there may be difficulty in practices releasing nurses to attend meetings. ACTION: AP to feed back the decision to Elaine Cook. CAMHS 14.1 BA reported his concerns regarding questions asked on the CAMHS referral form that he feels are not ones that can easily be answered by a GP, and arguably need to be answered by the service when the patient is seen e.g.“What does the parent expect from this referral?”. BA has spoken to Dr Rao, the Associate Medical Director – CAMHS, and raised the issues. BA suggested that Dr Rao be invited to a future Steering Group Meeting which was agreed. 14.2 PK agreed with BA and reported that he was asked if he could clarify what teachers think and if there had been involvement from other agencies. Dr Rao told BA that there had been a cut in funding so there is no proper screening of the referrals and they are trying to cope with a lot of work with less money. AW stated that CAMHS has a tariff deflator in terms of an internal CIP, but there has been no disinvestment in Mental Health Services. AP suggested that maybe Dr Rao is missing the point and that the problem lay with the questions and the responses expected – the question being asked is whether they are questions the GP should be asked. AP described her knowledge of a CAMHS service in an adjacent health economy in which the questions causing concern were part of the initial referral appointment discussion/assessment. 14.3 BA stated that CAMHS also require the form to be signed by the parent stating that they agree that information can be shared with other agencies before the referral can take place. BA has spoken to Lisa Hill who agrees that the form needs reviewing. ACTION: AP to invite Dr Rao to a future Steering Group Meeting. 15.0 15.1 Any Other Business AP reported that Dr Hirani has agreed to be the SHA Cardiology Lead. There is no MSK lead and this is now urgently needed as the risk is that changes to services are made with no input from the locality. 15.2 AP stated that there have been 8 volunteers to attend the two SWBH Community Nursing LiA events from SHA. 15.3 DH stated that he attends the Patient and Partnerships Advisory Group meeting and asked if this 11 Enc 14 could be added to the agenda as a standard item. They have looked at the Terms of Reference and are looking at the Remuneration Policy. A piece of work has been done by Jonathon Bostick developing an Information Portal which will be part of the CCG website. There will be another PPAG meeting tomorrow and Jon Dicken will be there to talk about the CCG’s strategic aims and the workplan. 15.4 SC raised a quality issue regarding one of her pregnant patients. She was diagnosed with having an ectopic pregnancy and the tube was removed prior to her being referred to the fertility service. The patient then had a scan in Poland and was still sixteen weeks pregnant. SC was advised to submit an incident form so that Claire Parker will pick this issue up. ACTION: SC to complete an incident patient for expectant patient. 15.5 BA has sent an incident form regarding an injection given by a District Nurse. It was unknown who had prescribed the injection, but the patient’s name was on the box. The chemist, Boots, was contacted and they said that the wrong name had been put on the box. 15.6 HP reported that Medicines Management has under spent. The practices will be asked to work with Medicines Management to understand current practice and provide assurance that patients are benefitting from the range of interventions available. 16.0 ACTION: HP to meet with AP to discuss under spending SHA practices in relation to Medicines Management Date and Time of Next Meeting Tuesday 26th March 2013 1.00 – 4.00pm Oakwood Health Centre ACTIONS WHO BY WHEN Meeting 23/10/12 6.8 LM to provide Lymphodema performance information before the next Board LM meeting. 26/03/13 12.3.1 AP has contacted PK about taking on the SHA Demand Management locality PK lead role. PK to find out more in relation to what is involved and assess whether the role can be fulfilled given his finance & performance lead commitments. 26/03/13 Meeting 20/11/12 3.3.7 AA reported that he had intended to raise the issue of X-ray reporting at AA Sandwell Hospital under AOB at the last Quality & Safety Committee but the Francis Report led to the need to take this to the next meeting - action carried forward. . 12 26/03/13 Enc 14 5.2 PK confirmed that the locality referral report for 2012/13 had been sent out by Laura Mainwaring. PK 26/03/13 7.4 Steering Group agenda item to advise members that instances where pharmaceutical companies were contacting GPs directly need to be reported to Medicines Management. AP 09/04/13 11.1.4 EC sent AP a report just before the meeting so there has been no time to review this. It was agreed that this will be carried over to the following meeting. AP 26/03/13 PK 26/03/13 5.9 MD to organise training on MICS. The decision regarding how to roll out training on MICS in the locality to be taken to a future Steering Group meeting (AP). MD 26/03/13 5.12 AW 26/03/13 7.5 PH is to confirm which three legacy estate schemes in primary care are being taken forward at the next Committee meeting. PH 26/03/13 9.1 PH to take YPH Outpatient Proposal back to SCR to emphasise Board concerns regarding process for the scheme going forward. PH 26/03/13 10.4 AP to circulate the Respiratory Pilot status information prior to the next AP meeting. 26/03/13 AP to ensure LCG PLT an agenda item for next Committee meeting. AP 26/03/13 13.2 AP to obtain costing of alternative venues for Steering Group meetings and bring back to the next meeting. AP 26/03/13 13.3 14.3 AP AP 26/03/13 09/04/13 15.6 HP to meet with AP to discuss under spending SHA practices in relation to AP Medicines Management 26/03/13 Meeting 22/01/13 Meeting 26/2/13 5.7 PK to bring back a report in relation to outpatient referrals performance 12/13 to a future Board meeting. 12.1 13 AW to liaise with JG and send a communication to LCGs. AP to feed back the decision to Elaine Cook. AP to invite Dr Rao to a future Steering Group Meeting. Enc 15 Minutes of the Black Country LCG Members Committee held: Thursday 21 February 2013, 13.00 - 15.00pm Tipton Sports Academy Present: Dr G Solomon (GS) Dr I Walton (IW) Dr A Saini (AS) Tanya Cooper (TC) Dr S Sharma (SS) Dr C Leadbeater (CL) Dr D Gahle (DG) Dr Aggarwal Kiran Lali (KL) Pam Jones (PJ) Naurin Akhtar (NA) Dr A Indwar (AI) Doug Round (DR) Dr D Hamilton (DH) Linda Lamb (LL) Dr P Desai (PD) Pam Bradbury (PB) Black Country Family Practice Horseley Heath Tividale Family Practice Black Country Family Practice Swanpool Medical Centre, Sharma & Sharma Swanpool Medical Centre, Leadbeater & Bhimji Warley Medical Centre Rowley Regis Hospital Finance Manager, SWBCCG Patient Lay Representative The Victoria Surgery 19 Walford Street Lay Member Regis Medical Centre Tipton Community Organisation Whiteheath Clinic Regional Director, NHS111 Apologies Dr T Crossley (TC) Carla Evans (CE) Ray Sullivan (RS) Dr Ian Sykes (IS) Malling Health SWB CCG, Senior Commissioning Manager Glebefields Health Centre Oakham Surgery 1.0 Welcome and Apologies 1.1 GS welcomed all to the meeting. 2.0 Declarations of any Interest on Agenda Items for Discussion 2.1 No declarations of interest were recorded. 3.0 Minutes and Actions from the Previous Meeting 3.1 The minutes dated Thursday 20 December 2012 were declared an accurate record of discussions. 1 Enc 15 Action Register 3.1.1 – invite to Jyoti – as Carla is away this will need to be confirmed with her on her return. 5.1.7 – codes and password – some members are still to action 5.2.4 – Partnership team – quarterly meeting – GS confirmed that this has been actioned 6.1.5 – Referral patterns across 2011/2012/2013 - KL confirmed that an e-mail and attachment had now been sent to all practices 4.0 Chairman’s Communications 4.1 GS informed members of the following: Authorisation – the CCG has now received its authorisation, from April 2013 it will become a statutory body. Due to an increase in the number of Officers, the staff team at Kingston House have recently moved to 4th floor rear. Clinical Leads – in order to appoint to a number of clinical lead roles, the first set of interviews have taken place 21/02/13 (today). Contract negotiations – these are on-going for the main contracts Mental Health (reviewing agreements with Local Authority) – currently on-going Innovation schemes – the schemes are now to be evaluated to decide which schemes to take forward 5.0 ITEMS FOR INFORMATION/DISCUSSION 5.1 NHS111 GS introduced Pam Bradbury, NHS111 Regional Director, going on to say that NHS Direct were successful in their winning bid to run the new service which will be launched in the West Midlands on 19th March 2013, commencing with a ‘soft launch’ before being rolled out with a national programme of media coverage. 5.1.1 This introduction was followed with a presentation from PB who gave members an overview of the new service, stating that: 5.1.2 The following core principles of the new service have been identified as: 1. Completion of a clinical assessment on the first call 2. Ability to refer callers to other providers – without re-triage 3. Transfer clinical assessment data to other providers and book appointments where appropriate and agreed 4. Ability to dispatch an ambulance without delay 5. Provision of health information or reassurance about what to do next 2 Enc 15 5.1.3 PB explained that 111 is not a service to replace 999 and will not change GP practice. NHS111 will operate through the use of non clinical call handlers who will work through a series of scenarios and options before closing the call. PB advised that, in case of Out of Hours cover, surgery telephone messages will need to change to reflect the new contact details. PB referred to the Directory of Services (DoS) which will need to be populated by practices. 5.1.4 PB welcomed questions from members, who asked a lot of pertinent questions. Below are examples of a two such questions. Q 1: one member asked how the organisation differs from NHS Direct in terms of size and number of staff. A: PB advised previously 33 call centres with 4000 staff, which has now been reduced in number to six call centres, with the local operations being run from a call centre in Dudley. PB pointed out that NHS Direct did not secure the whole contract but won 33% of the business. Q 2: Dr Desai asked who maintains the DoS A: PB advised that a lady by the name of Louise is the DoS manager for the region and that it for practices to work with her to ensure that the directory is populated. 5.1.5 PB mentioned that all information delivered at this meeting would also be sent out to all practices for their perusal. And in response to another question she advised that referrals to GP’s surgery following a patients contact with NHS111 is showing from early analysis to be around 1 per 1000 patient population. 5.2 5.2.1 Ophthalmology Clinics at Rowley Regis Hospital SA discussed the provision of an eye care service, whose aim is to provide a one stop service. This has already been operating for the last 18 months. The clinic is consultant lead with experienced specialist nurses or associated specialist doctors. The service is listed on Choose and Book, but a referral can be send via letter or in the case of an emergency by phone. Following referral patients attend for surgery with one follow-up appointment thereafter. The clinics run Tuesday to Friday. Emergencies can be booked in within a fortnight. 5.2.2 A member asked, ‘what are the advantages to the patient over services run by the acute sector’. SA said that waiting times are lower (In general patients are seen within 2-4 weeks), plus it is a one stop service held in the community. A member asked why is a similar service not provided at Sandwell. SA confirmed that there is, but as part of RCRH, services are also being moved out into the community. 6.0 6.1 6.1.1 LCG OPERATIONAL BUSINESS Finance and Performance update KL provided a summary of the finance report at the end of month 9 (December), 3 Enc 15 informing members that a year to date deficit of £2.6m has been recorded. CCG has a surplus of £1.6m, and is forecast to under spend by £6.5m largely due to PCT control target. Referring to page 3, KL explained the position that the CCG hopes to be in by the end of the year. For Dudley group an under spend of £683,000 has been forecasted, although £175,000 has been allocated to Black Country mainly due to reporting on Maternity Services. With regards to the forecast outturn position, no agreement has been reached for the end of the year. Walsall - status is consistent with the figures reported as of last month. Birmingham Women’s – a decision has been made to raise internal cap on births from 7,200 to 8,000 which has brought about a slight overspend. Prescribing – for the CCG as a whole a surplus of £2.4m year to date has been reported. Innovation funds – a budget of £530, 000 was set aside, of which £189,000 has been utilised which leaves an under spend of £341,000. The bottom line is that the CCG are due to over spent mainly at Sandwell and West Birmingham. 6.2 6.2.1 Quality and Safety update The issues with regards to the Francis report were raised where a member posed the question ‘how does each LCG take responsibility for monitoring the quality of secondary care’. And, ‘how do practices report in concerns that have been raised by patients’. ‘Is there a process?’ GS responded by saying that there is a process which is being developed at the moment. He also went on to say that one of the recommendations of the Francis report is that the CCG report and monitor patients concerns, acting on issues raised. 6.2.2 One GP suggested that patients complete a satisfaction survey on discharge from hospital, responses of which can then be feedback to the local CCG responsible for the contract. GS said that this is one idea, although recognised that not all patients would complete a survey. GS said there will be an opportunity to discuss further as more guidance is provided. 6.3 6.4 6.4.1 Strategic Commissioning and redesign update As discussed earlier Partnership Committee update SM provided members with the following update, saying that Sharon Liggins had completed a scoping exercise to clarify the financial resources of the CCG and to look at partnership working with the Local Authority. SM noted that historically the PCT has supported pooled budgets and additionally has given out grants to support community agendas. Some of which will cease in the new financial year. Adult Social Care have to reduce their expenditure by £20bn over the next two years, which will have an overall impact on health care budgets. In addition, there 4 Enc 15 will be a cap on benefits, the impact of which may be seen in Primary Care as GP’s are often the first port of call when families are in crisis. The Drug and Alcohol service is likely to be redesigned when its current contract comes to an end. 6.5 6.5.1 Attendance and Future Configuration of LCG Meetings (ENC 1) GS explained that the paper was in two parts, the first part being attendance at meetings, two practices have not attended to date, whilst other practices have varying levels of attendance from 40 – 100%. GS reminded members that there is a payment made to practices to ensure they are all represented and engage with LCG. GS was keen to understand the barriers which are preventing fuller participation from all member practices, i.e. meeting times, day, duration and so on. To explore this further GS opened up discussion. 6.5.2 Members discussed alternating meetings. It was agreed that Thursdays would be the best day in the week. One member said that it might be worth contacting the worst offending practices, particularly where there has been very low or no attendance. That way you can get at the root of the issue as it affects them. 6.5.3 The second part of the paper discussed bi-monthly meetings. GS advised that there has been a suggestion that members meet on a bi-monthly basis, alternating the Members group and Board meeting. So every two month’s there would be a larger members meeting with a meeting in between where actions can be picked up and taken forward. 6.5.4 Decision: after much discussion it was agreed that the Members and Board and meetings should be held on a bi-monthly basis, alternating each month taking place on a Thursday as this is the day that works best for practice members. 6.6 6.6.1 LCG Commissioning Intentions GS asked members to think about areas for consideration. Early suggestions, were: 1. IV – Antibiotics 2. DVT pathway 3. Minor injuries 6.6.2 Members discussed the merits of the above ideas. GS stated that item 1 & 2 may well be picked up by the CCG in any case and that due to the low uptake and cost of setting up and running a minor injuries service it may not prove feasible to take forward. 5 Enc 15 6.6.3 GS asked members to give this matter some greater consideration, e-mailing himself or Carla with further suggestions which come to mind. 7.0 Close 8.0 Date and Time of Next Meeting 8.1 18 April 2013, 13:00 – 15:00PM, Tipton Sports Academy 6 Enc 15 Action Register Item No Action By Complete/Resolved 7 14th April 2013 Enc No 16 ICOF Board Meeting Minutes Minutes of the ICOF LCG Board Meeting held on Thursday 21 March 2013, 12.30-3pm, at Aston Pride Health Centre Present: Dr S Mukherjee Dr I Marok Linda Baldwin Bi, Sobia Mohammed Khalil Dr S Sarwar Chris Vaughan Mango Hoto ICOF LCG Chair ICOF LCG Vice-Chair Business Support Officer Finance Manager Senior Commissioning Manager ICOF Board Member ICOF Board Member, Patient Representative ICOF Board Member, Patient Representative In attendance: Phil Lydon Patient and Public Involvement Commissioning Manager Apologies: Mary Mungovan Dr R Muralidhar Dr M Aslam Dr M Sinha ICOF Board Member, Practice Nurse ICOF Board Member ICOF Board Member ICOF Board Member Item 1. Subject INTRODUCTION Welcome, Introductions and apologies Dr Mukherjee welcomed everyone to the meeting. Apologies as noted above. 2. Declarations of Interest All doctors declared an interest 3. 3.1 Minutes of Previous Meeting/Action Register Declared as a true record of discussion of the meeting held on 21 March 2013. 3.1.1 Members progressively worked through the action register, all items of which are to be picked up on day’s agenda 4. 4.1 Chairman’s report Dr Mukherjee provided the following updates: NHS111 – it is expected that there may be pressure in the system due to the roll out of the service on 19 April and the Easter holiday period. Bed capacity – is at saturation point in a number of hospitals, managers are working hard to resolve and come up with a solution. SWBH is increasing capacity front end. GP’s are to look at pre and post Easter access and make sure there is plenty of available access. It was agreed that people with known long care conditions should be seen before the Easter period to ensure that they are safe and well and that their needs are being attended to. Repeat Prescriptions – notification is to be given to patients to remind them that as practices and most pharmacies will be closed over the Easter holiday that they should collect repeat prescriptions beforehand. 1 Item Subject Delayed Transfer of Care – the LCG are to ask for a list from SWBH which will be given to practices to inform them of patients that may need help. Communications – leaflets will be distributed ahead of the Easter break to inform members of the public what to do in the case of sickness or an emergency 5. 5.1 ITEMS FOR INFORMATION TB Training – 28 March 2013 It was agreed that an e-mail should be sent to members to remind them of the date. It was confirmed that all other arrangements were in hand. A number of sponsors will be supporting the event. 6. 6.1 6.1.1 ITEMS FOR DECISION RAC Evaluation MK advised members that ICOF have now received a 3 month extension from the Strategic Commissioning Review Planning meeting, which will allow ICOF time to work up a revised model. MK asked who would lead on this piece of work and what input will be required from the board and practices. Also looking ahead, ICOF need to look at options to see how the service can continue beyond the 3 month time period. To enable these discussions to take place, MK suggested setting up a progress group. MK also mentioned the work that the CCG is conducting to improve Demand Management; they are currently looking to introduce Map of Medicine across all LCG’s. 6.1.2 Dr Mukherjee thoughts were that ICOF can’t release RAC until a suitable replacement is found, or until RAC has been developed into an effective model (whichever of the two is taken forward). Dr Marok expressed concerns that GP’s are now engaging with RAC having built it up over the last two years and are now starting to see reductions in referrals; if the CCG changes over to another system GP’s may not share the same enthusiasm for its introduction. MK advised that would need to look at the costs and the risks; software may also need to be reviewed to make the process more automated. Dr Marok suggested using both systems in parallel to see how one compares to the other. 6.1.3 Action: LB to set up a meeting to discuss the future of RAC – looking to a date mid April and setting aside two hours for discussion. Dr Mukherjee, Dr Marok (if available), MK, MP and Osman Majothi to attend. May also consider inviting Matthew Maguire. 4 meetings to be held in total. 6.2 ICOF Board – Nurse and Practice Manager representative Deferred to the next meeting 7. 7.1 ITEMS FOR DISCUSSION Pharmacy Review Project Plan 7.1.1 Dal Sidhu provided an update on the project: Phase 1 – all simple switches have now been completed, generating savings to date of £162,000 Phase 2 – A further £176,000 of potential savings were highlighted at this stage, but are dependent on further work in practice. Care Home Pilot (Phase 3) – the pharmacist has commenced visits to 5 care homes and plans to carry out a medicine reviews for all identified patients. It was hoped that it would be possible for Care Homes’ staff to receive medicines management training, but this is now looking unlikely given the limited time available. Staff have expressed an interest in receiving the training should it become available. 7.1.2 2 DS informed members that by the time the project comes to a close potential savings in the region of £385,000 should have been achievable or the LCG will be on target to achieve such sums. However, Item Subject despite such promising news, to date only 3.5% of these savings have actually been realised. This could be due to a number of reasons; it could take 6/9 months before the effects of the medicine management work can be fully seen in terms of savings. The Prescribing Advisor for ICOF (Sajjad Raja) should be able to follow through on any identified savings made over the last few months to ensure that they come to fruition. Dr Mukherjee also suggested that in parallel to the work of the CCG, ICOF could do some work of their own. 7.1.3 In addition, DS mentioned some further savings that have been picked up over recent days, which could bring in a further £79, 000 worth of savings, this related to calcium medications. Dr Mukherjee suggested that DS and Sajjad arrange a handover where all of the above identified savings can be made known and passed on. 7.1.4 CV enquired about recent news coverage around the effectiveness of prescribing antibiotics over a long period. DS advised that this has been a known issue for some time, and GP’s are reminded of this. 7.1.5 As this was DS’s last meeting Dr Mukherjee thanked Dal and his team for all their hard work. Dal also expressed thanks to ICOF for giving him the opportunity to work with the Board and practices. 7.2 7.2.1 Finance Report Sobia reported on month 10 (January 2013), saying that year to date figures show that ICOF have generated a deficit of £221k which is expected to rise to £497k by year end. Expenditure on most areas of reporting have remained consistent (Table 1 provides an overall picture). The performance of the CCG as a whole is showing a year to date under spend position of £5.9m, which is set to rise by a further £3m come the end of the financial year. A financial surplus of £8.7m is predicted by the end of the financial year on an overall budget of £655m. With agreement from the SHA Sandwell PCT has increased its forecast to £9.966m. 7.2.2 Hospital expenditure SWBH – An agreement has been reached over the financial outturn with Performance at Sandwell and West Birmingham NHS Trust, agreed at £3.3m. UHB – the trust has reported 6% over performance. At present SWB CCG are reporting £2.184m, or 10%, above planned levels. 7.2.3 QIPP SB referred to Table 3 to demonstrate QIPP performance for this reporting period. SWBCCG is currently forecast to be £817k under target by the end of the financial year. 7.2.4 Financial risk The main risks have been recorded as follows: • • • Acute over performance - £537k Decommissioning Targets under achieved - £333k Restructuring - £1.9m Bringing a total of £2.8m set against risk 7.3 7.3.1 Innovation Funds ICOF have utilised £201k of their allocated budget of £510k. MK and SB advised that provision has been made for all payments which will be paid out in the coming weeks. Dr Mukherjee advised that no innovation monies have been set aside in the next financial year 2013/14. 7.3.2 Members discussed the spending and allocations of the other LCG’s. Some CCG member organisations have spent a greater part of their allocated funding. Healthworks for example have spent all but £29k 3 Item Subject of their allocated budget of £630k. 7.3.3 Dr Marok reminded SB that she was to provide practice level reporting. SB said that she has had difficulty in obtaining this information, but would try again. 7.3.4 Innovation Projects 2012/13 update: MK brought members up to date, as follows: Immunology – are now running 6 clinics, patients uptake has increased which has allowed the model to be tested. An evaluation will be completed. Patient flow through the RAC has also been very good. Ophthalmology – Slow start. Pioneers for Health have started to use the RAC more frequently after a delayed start. Computer literacy could have been a problem. BP Monitors – the majority of practices have now ordered the equipment. 2 practices have decided not to take advantage of the funding. LB is currently chasing practices for copy invoices and is also waiting on some Service Level Agreements. Demand & Access – some practices have now had their training, whilst others have booked for future dates. Because of year end returns members have been asked to submit invoices for reimbursement ahead of the training. Again, LB is chasing all invoices to ensure payments are processed before finances close for the year. Reducing Emergency Admissions – as well as the return of Service Level Agreements to mark participation, we are still waiting on the monthly returns for most practices. Month 1 (January) and Month 2 (February) should now be in hand for all practices, with Month 3 (March) being expected early April. LB to continue to chase for this information. 7.3.5 Members agreed that there had been some communication and system capability problems, as well as some less than timely responses to requests, which would need to be considered when similar work is entered into in the future. Dr Mukherjee recognised the pressures and thanked everyone for their efforts. 7.4 7.4.1 Patient Summit Members discussed the timing of the Summit and the topics of discussion. It was thought that a very early meeting might not leave enough time for preparation, and for those patients who are engaging, too late a date might prove difficult. Members agreed that April would be too soon; therefore 9 May 2013 was settled on, to take place over a lunchtime. MH suggested a Saturday, but members advised that this would not work for everyone. Based on past experience of running such events PL provided some guidance on what might work well, not so well. PL requested a patient list from Patient Network. MH to supply PL with a list. CV has already forwarded another list. Dr Mukherjee suggested PL asked practices for their PPG list. 7.4.2 Members were asked to hold the following date in their diaries: Date: Thursday 9 May 2013 Time: 13:30 – 16:00PM approx Venue: TBC 7.4.3 In the meantime, PL will work with patients and practices to decide on a programme and inform them of the date, and arrangements for the day. Another inroad would be for PL to go along to PPG meetings. Members suggested potential venues which PL will look into. 7.5 7.5.1 LCG PLT Events MK advised members that there would be two CCG wide PLT events. In addition, each LCG would hold two PLT events of their own. MK said that an indicative budget of £5000 to include Out of Hours cover had been set for each LCG event. From there, MK tried to gauge people’s ideas on when to hold, topics of discussions, who will lead on the events, so on and so forth. 4 Item 7.5.2 Subject After discussion, members decided on the following dates: • • Tuesday 11 June 2013, 12:30 – 16:30PM, Venue TBC Tuesday 10 September 2013, 12:30 – 16:30PM, Venue TBC 7.5.3 It was agreed that a meeting needs to be held outside of the Board to discuss the agenda, building up to the events as they occur. Both PLT events will be open to GP’s, PM’s, PN’s and HCA. As Dr Matthew Nye has facilitated discussions for similar events in the past, members agreed he should be asked if he would be happy to do so again. MK pointed out that no additional payment would be made to clinicians for providing support. CV asked as a Patient representative, if an agenda item could be included to identify the relationship between general practice and Public Health, especially given that the CCG no longer has the remit for public health which has now moved over to Local Authority. 7.5.4 In relation to the above, CV asked if each LCG has its own Medical Director. Dr Mukherjee confirmed that there is no Medical Director at either LCG or CCG level, but Dr Steve Cartwright fulfils the role for the Local Area Teams. 8. Any Other Business None discussed 9. DATE AND TIME OF NEXT MEETING Tuesday 16 April 2013, 12.30pm Aston Pride Health Centre CLOSE OF MEETING 5 Enc 17 Enc 17 Healthworks Locality Commissioning Group Committee (Board) Meeting Tuesday 12th March 2013 Meeting Minutes Attendees: Dr Nick Harding (NH) Dr Niti Pall (NP) Keith Eden (KE) Dr Simon Butler (SB) Dr Gwyn Harris (GH) Dr Liz England (LE) Dr Mark Foulerton (MF) Diane Charles (DC) John Cash (JC) Chair Vice Chair Finance and Performance Lead Redesign Lead Prescribing Quality and Safety Lead Partnerships Lead Patient Representative Patient Representative In Attendance: Sally Sandel (SS) Jayne Salter-Scott (JSS) Paul Southon Jonathon Woodstock (JW) Senior Commissioning Manager Senior Commissioning Manager (Engagement) Public Health Development Manager, Sandwell MBC People Matters Network Apologies: None Agenda Item Discussion Action 1. Introduction 1.1 Welcome and Introductions NH welcomed everyone to the meeting. 1.2 Absence and Apologies Noted as above. 1.3 Declarations of Interest It was agreed that declarations would be made as appropriate at the relevant agenda item. 1.4 Minutes of Previous Meeting It was agreed that the minutes were a true and accurate record of the meeting 1.5 Matters Arising/Actions There were no matters arising 1 Enc 17 2. Feedback from CCG Board / Communities 2.1 AO’s Governing Body Report NH reported that City and Sandwell were not routinely hitting the 95% four hour target for Urgent Care. There was a Cross Birmingham Urgent Care Summit yesterday where it was reported that while Urgent Care was busy throughout the whole of the UK, Birmingham is at the nadir of this. As a consequence most of the Urgent Care Systems will have to remain open through Easter at least. SB reported that Healthworks have committed a large amount of money to Urgent Care projects – Vitality through City Hospital and Carters Green through Sandwell Hospital and there has been engagement with both City and Sandwell A & E Departments to attract people away from A & E. They are Innovation Fund projects and despite three attempts to go live, no patients were seen and the scheme has therefore now been withdrawn. LE raised the question as to whether the problem lay with City or Sandwell. SB replied that Sandwell has a GP service in A & E and is refusing to send patients to their own GP and from the 1st March the CCG gave City a large amount of money to enable the creation of a solution and they brought in the same GPs so both hospitals now have the same service. JSS advised the group that the engagement team have been doing a piece of work, which involved visiting the A & E departments to find out why people are there. The early results of this are: • • • 50% of patients could have been treated elsewhere. Many patients did not know that there are walk-in centres and other ways of accessing services. A considerable number reported that they had been referred by their GP. She suggested that it would be useful to bring the completed report to the next meeting for discussion. LE stated that there has been a similar project looking at the reasons that people call an ambulance and the results were fairly similar. NH reported that there is to be a Transformation Team and their first project will be to redesign the Urgent Care system. 2.2 CCG Governing Body Minutes There were no matters arising from these minutes. 2.3 Commissioning and Redesign Committee MF reported that the soft launch of the NHS 111 service will be on 19th March and the full launch will be two or three weeks later. At the meeting there was an update of the SWBCC Contracts Evaluation that is being carried out by Atkins and MF reported that 2 JSS Enc 17 there is to be a presentation on the results of all the evaluations at the end of March. SB stated that the date had been set as the 11th April. MF reported that there was an update in regards to the diabetes redesign plans which involve greater support for practices to care for diabetic patients including training for staff, joint consultation clinics, and a local incentive scheme for diabetes which is still ongoing. JC raised the question as to whether any of the group had any contact with local diabetes groups. NP stated that she does. MF reported that there was an agreement that the Maternity Services specification is to be added to the SML Birmingham Hospitals contract including the local Key Performance Indicators. Looking ahead the group were looking at changing the provider via an AQP. They are looking at One-to-One which is being run in the Wirral. He ended by stating that the final decision is still to be made in regard to the bungalows as there was not enough financial information. 2.4 Finance and Performance Committee This will be KE‘s last meeting and NH, DC and JC all thanked him for all his hard work. KE stated that the Finance and Performance Committee has not met since the last Healthworks Committee Meeting and they are still waiting for the league tables that they had agreed to distribute to the practices. He stated that the work will really start when his successor is appointed. 2.5 Quality and Safety Committee LE reported that there had been a long presentation in regards to a diabetes study comparing the benefits of different treatments. The committee were asked for £64K which raised the question of the budgets for research. LE stated that committee was unsure of these and is trying to gather some more information. She stated that the group had discussed the Francis Report. It is going to be thematically analysed and the first theme was to look at how complaints and significant events are triangulated and the Datix System which will be implemented on the Birmingham side. LE stated that her understanding is that Sandwell GPs already use Datix and it allows them to record any significant events and any information around clinical events which is then sent to the Quality and Safety Committee for correlation. It has been specifically designed to allow anyone in the practice to report into it. It is going to be rolled out towards the end of May. LE updated the group that the Emergency Departments were visited on Friday and that the consensus of opinion was that the quality and safety is improving there. She raised the question as to whether the CCG should be funding audits. She stated that there had been a presentation on audits and 3 Enc 17 there was the idea that if an external provider was going to carry out strategic audits then the tender would have to be put out to AQP. 2.6 Partnerships Committee MF advised the group that he had received a report from the Quality and Diversity sub-committee which agreed on a single equality priority for the next year. The priority is to improve the uptake and quality of Primary Care Services among new migrant communities. He reported that there was a long discussion on the Joint Commissioning Team Report on Learning Disability Services commissioned by Birmingham City Council which include Continuing Healthcare Services and out of area management for the Birmingham Community Healthcare Learning Disability Speciality Services. MF ended by stating that there was an update of the Partnership arrangements with Birmingham City Council and CCGs. 2.7 Feedback From Patient Representatives JC stated that the patient representatives were a part of the team carrying out the surveys in A & E. They used the Smartkit a handheld tablet, which worked quite well. DC stated that she was concerned regarding some of the questions. There were five requesting details in regards to ethnicity and none of the patients surveyed were asked how long they had been waiting. JSS replied that the questions followed on from an academic piece of research commissioned from one of the Birmingham Universities and all the questions had been tested. She stated that she will liaise with DC to have a more detailed conversation. JC raised the issue of drug budgets and asked if it was true that some patients ‘hoard’ drugs. GH replied that it does happen but that the matter is in hand, particularly looking at repeat requests from patients and pharmacists. The Medicines Management Team are actively engaging with Practices to discuss the problem so that when the Practices are more aware they can get the member of staff responsible for repeat prescriptions to look at how frequently medicines are being ordered and have awareness of how often certain medicines need to be ordered. He stated that the Practices who are engaging with the Medicines Management Team have already made savings in the cost of medicines. With regards to patients who are prescribed medicines but do not take them that is a more difficult problem. Leading on from this SB raised the question of dressings. There have been conversations for years regarding centralised dressings stores. SB enquired as to whether this has progressed at all. GH replied that at the moment a restricted dressings formulary is being considered. The team is also considering a return to pre-printed dressings prescriptions. Dudley PCT has already implemented this with some success. NP reported that nursing homes are currently being reviewed with regard to the number of dressings they use. 4 Enc 17 NH advised the group that he gave a talk at Link-Sandwell. NP reported that Healthwatch are currently recruiting. They are looking for candidates with HR and Finance experience. 3. Items for Decision/Agreement 3.1 Vitality Partnership Outpatient Plan It was agreed to begin with Innovations Funding update. SS reported that Kally Judge is now in post. She is trying to ascertain progress against the milestones that have been put in place within the funding agreements. KJ has met with a few project leads or project sponsors but has not met with everyone yet. Finance have confirmed the funding situation in that all money must be spent by 31st March. The evaluation approach has now been agreed and an email should be going out within the next couple of days to confirm. It will include the evaluation template. This template need not necessarily be used but it includes the things that would be expected to be in an evaluation. NP thanked SS for all her hard work on this project. SB stated that Vitality Partnership Outpatient Plan was put together following a discussion with George Solomon (the SCR lead) regarding concerns raised about what to do with the existing Innovation Funds Project. HealthWorks are working slightly differently to other areas and new services have been created delivering a change in care pathways locally. In particular those going through are urology, ENT, physiotherapy, immunology, PVD and dementia. These are due to cease on 31st March and SB questioned this, as change was being delivered and the process was still to be evaluated. All of the different schemes are a change of care process but there is no CCG leadership or strategy in some of these areas and they are the starting point for bigger pieces of work. He asked what can be done and as there is no leadership or strategy….perhaps if effect could be evidenced over an extended period of time some of the processes could be taken on. He asked if provider lead leadership is to be allowed into the organisation. NP stated that KE, MF, JC, DC, and herself would vote on this. She further stated that the decision made at this meeting will have an effect on all the other Innovation Fund projects. She urged the group to seriously consider the effect of stopping these services as it is saving money and it is providing a quality service. A precedent has been set in the Black Country Commissioning Group by which this has been accepted as the norm going forward. SS stated that this has been raised at SCR and asked if SB had received any feedback. SB replied that it was approved at SCR for delivering service in the Rowley area and then went back to SCR recently to propose extending the service to Carters Green. However there was a question regarding funding. But the principal was approved and the money was approved for Rowley. SS stated that this is because they have decommissioned series at SWBH 5 Enc 17 NP asked for comment from the group and the consensus was that services are good; evaluation is necessary, and that on the whole, these schemes needed to continue. NP, KE, MF, JC and DC were all in agreement. 4. Items for Discussion/Information 4.1 Impact of Welfare Reforms PS gave a presentation regarding the impact of welfare reforms. The areas that will be affected are : • Housing benefit • Council Tax Benefit • Social Fund/Crisis loans • Incapacity benefit – ESA • DLA – Personal Independence Payments • Child Benefits and child maintenance earnings thresholds • Working Tax Credits thresholds A benefits cap and a Universal Credit System will also be introduced. As part of the presentation there were some scenarios showing how the changes will affect the income of a variety of families and the possible impacts this will have in regards to health. 4.2 Prescribing Update GH reported that he had presented some data at the Member’s Event. He extended his thanks to NP for all her help. He reported that there was one key marker the committee looked at which was cost effective and evidence-based prescribing of cholesterol lowering drugs. This LCG has shown the greatest improvement in savings. It was agreed that there would be a more detailed report at the next meeting. 4.3 Patient Participation NP introduced JW from People Matters which is the company invested in to take some of the on-line patient participation material. He gave a presentation showing a draft version of the Patient Summit website which is ready to go live. 4.4 Patient Summit There was a discussion regarding the agenda for the Patient Summit. NP had some concerns regarding the current agenda and asked for volunteers to draft an alternative. It was agreed that the dates will also need to be amended. It was also agreed that the Committee should drive this and truly sign-up to it. This was agreed. NH Left the meeting. 4.5 QP Support - Moving Forward SB reported that GP Practices should be submitting their QP on 31st 6 GH Enc 17 March 2013. The last data that came out of BSOL was in July. There is a very quick piece of work being done in the CCG but the data to support the submission will not be collected fast enough. He reported that NH and the chair of BSOL are talking regarding the submission of QP without any data. 5. Any Other Business 5.1 Elections – Finance and Performance Lead SS reported that the elections timetable will be going out this week and that Celine Ryder had agreed to co-ordinate this. 5.2 Clinical Leads LE asked if anyone in the group knew who the clinical leads will be. SS replied that there will be an announcing once they have all been appointed. There are a couple of appointments still to be made. 5.2 PLTs SS reported that LCGs have the opportunity for two local PLTs funded through the CCG. NP suggested that the group contact SS with suggestions of who should be on the PLTs and the clinical training that is needed. 5.3 SCR SB reported that SCR has agreed that LES’s will be run for another six months during the evaluation process. BSOLs are disappearing and the Practices will need a document advising them of the six month extension. SB is to draft a document for NH to sign. 6. Date and Time of Next Meeting 6.1 The next meeting will be on 16th April 2013 at 12.30 pm 7 All SB